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"The development of science and of the creative activities of the spirit in 
general requires still another kind of freedom, which may be characterized 
as inward freedom. It is this freedom of the spirit, which consists in the 
independence of thought from the restrictions of authoritarian and social 
prejudice as well as from unphilosophical routinizing and habit in general."
Albert Einstein (1879-1955)
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11INTRODUCTION AND OUTLINE OF THE THESIS
Introduction
Chronic low back pain is defined as an unpleasant sensory and emotional 
experience in the lumbosacral area lasting more than 3 months, with some 
people reporting referred pain to the upper leg. 
When the pain experience lasts less than 3 months we call it “acute pain”, 
whereas “chronic pain” represents pain lasting longer than 3 months1.  
The percentage of people changing from acute over to chronic low back pain  
is much higher than previously documented; instead of 8% as presented by  
the Quebec task force2, more recent studies report up to 65%3-6.
Low back pain was and continues to be a very common problem globally 
and its prevalence will increase over the next years7,8. Low back pain causes 
more global disability than any other condition and ranks highest in terms 
of disability and sixth in terms of overall burden8,9. The mean prevalence is 
estimated to be 9.4-11.9%, the one year prevalence 22-65% and the lifetime 
prevalence 84%8,10. With these numbers we can say that this burden poses a 
problem due to the health care consultations and working days lost. Besides 
being common, treatment of low back pain is also costly; 2% of all physician 
office visits are for low back pain complaints11.
Low back pain can be classified using a diverse set of classification systems. 
One such classification system distinguishes between “non-specific” and 
“specific” low back pain. The term “specific” low back pain is used when the 
pain is caused by a specific pathophysiological mechanism and “non-specific” 
when a specific somatic cause can’t be identified. In primary care, most of 
low back pain is classified as “non-specific” because the underlying pathology 
cannot be identified; however, a “specific” low back pain problem is present in 
cases such as hernia nuclei pulposi, vertebral compression fracture, infection or 
tumour. 
Regarding the spine related pain disorders, the vertebrae, intervertebral discs, 
facet joints and sacroiliac (SI) joints can act as a major cause of low back pain 
and of referred pain. The worldwide burden of osteoporotic vertebral fractures 
in the year 2000 was estimated to be 1.4 million12. The incidence of clinical 
osteoporotic vertebral fractures in The Netherlands was 0.7% in women and 
0.2% in men aged 55 years or older13. Traumatic spinal fractures occur in 11.8 
to 16.4 per 100000 population (0.012 to 0.016%)14,15. Being a frequent site 
of bone metastasis, spinal involvement occurs in up to 40% of patients with 
cancer16. Vertebral compression fractures occur in 55 to 70% of patients with 
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multiple myeloma17. The prevalence of internal disc disruption, facet joint pain 
or SI joint pain amongst the patients with chronic low back pain was estimated 
to be 39-42%18,19, 15-31%19,20 and 10-38%19,21-23, respectively. The younger the 
patient, the more likely low back pain is discogenic in origin19. 
Ruling out red flags is an important part of the diagnostic process24. Patients 
with low back pain can be referred to secondary care when they do not 
benefit from usual (conservative) treatment or when symptoms persist. 
Medical history, physical examination and additional tests performed by 
the pain physician (or another specialist) together may lead towards the 
working diagnosis of a “specific” (low back) pain source. A classification 
merely between “non-specific” and “specific” may provide insufficient insight 
and other classification systems are currently being introduced, e.g. between 
“degenerative” and “non-degenerative” disorders25.
Low back pain can occur as a result of conditions affecting the bony lumbar 
spine, the discs between the vertebrae, the ligaments around the spine and 
discs, the spinal cord and nerves, the muscles of the low back, internal organs 
of the pelvis and abdomen, and the skin covering the lumbar area. The 
assessment and interpretation of tests used to diagnose low back pain subtypes 
are often not standardized26. Identification of the pain-producing structure is 
not easy in (degenerative) spinal disease. Ageing affects the spinal elements and 
causes a certain degree of degeneration of these elements27. 
In assessing the association between deviations on spinal imaging and low back 
pain, the scientific research data yielded various results28. Patients with nerve 
compression due to disc herniation may report no pain29-32, while other patients 
without nerve root compression may report severe pain33-35. Apparently, the 
severity of pain is not correlated with the size of the herniation36-39. Features 
on imaging tests may have little prognostic value regarding the cause of the 
symptoms40-44.
Routine imaging tests are associated with radiation exposure and increased 
expenses and can possibly be unnecessary procedures45. Clinical practice 
guidelines for the diagnosis and treatment of low back pain have been 
developed in the past46. Appropriateness criteria for low back pain were issued 
by the American College of Radiology (1996, last revision 2011), rating the 
radiologic procedures and also taking into consideration the relative radiation 
level47.
In men, the cross-sectional diameter of the erector spinae and multifidus 
muscles at the lower lumbar level can be considered to be prognostic factors for 
chronic low back pain after acute trauma48. 
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Young et al. demonstrated that, regarding the diagnostic criteria, pain when 
rising from sitting, as well as axial, mid-line pain is associated with disc pain 
and that absence of pain when rising from sitting is associated with facet joint 
pain; SI joint pain appeared to be associated with three or more positive pain 
provocation tests, pain when rising from sitting, unilateral pain and absence 
of lumbar pain49. Hancock et al. found that axial, mid-line pain was the only 
clinical feature to increase the likelihood of the disc as being the source of 
pain. A combination of SI joint tests was informative, but single tests were 
not50. Arnbak et al. reported that, on examining the diagnostic value of three 
SI joint provocation tests, these tests were associated with sacroiliitis identified 
by MRI51. A systematic review of patient history and physical examination to 
diagnose chronic low back pain originating from the facet joints found that the 
evidence for the diagnostic accuracy is inconclusive and that therefore patient 
history and physical examination cannot be used as a substitute for the need of 
a diagnostic block52. 
When a patient with low back pain complaints visits his or her general 
physician or medical officer in the Dutch primary care setting and red flags are 
not suspected, a conservative period of six weeks is widely used. If the patient 
does not improve, he or she can be referred to secondary care. Long waiting 
times exist for appointments with pain physicians (or other specialties) in 
regular hospital settings. This health care system could be partly responsible for 
the chronification of low back pain. However, at this moment it is unknown 
whether treating the patient with low back pain in secondary care earlier in the 
process leads to better results.
Several reasons highlighting the need for change in the multidisciplinary 
management of chronic pain are presented in the consensus report by Kress 
et al.53, i.e. medical training, improvements in training for team members, 
adopting a patient-centered approach, universal guidelines and influencing 
political will on a national as well as international level. We have to know 
first what to offer our patients suffering from this burden of chronic low back 
pain. However, high-quality evidence of treatment possibilities that provide 
a good and long lasting treatment outcome (e.g. pain reduction and physical 
restoration) is lacking. 
There is moderate-quality evidence that self-management programmes have a 
moderate effect on pain intensity, and a small to moderate effect on disability54. 
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Although differing in design, studies on the effectiveness of multidisciplinary 
treatment of chronic low back pain reported patients to have benefitted from 
treatment, including experiencing pain reduction55-61. Studies on massage 
interventions and yoga indicate short-term improvement62-66. There is no 
high quality evidence to support the use of Pilates exercise programmes67. 
Combined physical and psychological treatments, medical yoga, information 
and education programmes, spinal manipulation and acupuncture appear to be 
cost-effective options for low back pain when compared with the study-specific 
comparators68. Spinal fusion should not be favoured when multidisciplinary 
programmes are available69. 
In patients with chronic, axial low back pain, there is a lack of effectiveness 
of interlaminar epidural steroid injections. In the case of radicular pain 
a statistically significant short-term improvement in pain is observed70. 
There is no conclusive high quality evidence supporting the effectiveness 
of radiofrequency (RF) in patients with chronic low back pain71-78. Cement 
augmentation provides better clinical outcome compared to non-surgical 
management79-82, although other studies demonstrate lack of effectiveness as 
compared to placebo83,84. In patients with cancer, balloon kyphoplasty (BKP) 
proved to be effective and safe85-91. 
Modern telehealth interventions are not more effective than minimal 
interventional treatment for reducing pain and disability92. 
Rationale and aims of the thesis
In view of the conflicting evidence for effectiveness of RF treatment in patients 
with chronic low back pain, a study was setup consisting of three RCTs 
investigating the effect of RF treatment of the SI joint, disc and facet joint 
in terms of pain relief and GPE. The RCTs studied the effect of respectively 
a RF lesion of the ramus dorsalis of the segmental nerve root for facet joint 
pain, an RF lesion with the Simplicity© III tool for SI joint pain and an RF 
lesion of the ramus communicans for disc pain. In a fourth study, the inter-
rater reliability of the diagnostic parameters of the physical examination was 
assessed and in a fifth study we evaluated the predictive validity of lumbar 
X-ray images and MRIs in determining the somatic source of low back pain. 
Finally, we observed the effectiveness of BKP in patients with painful vertebral 
compression fractures.
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Outline of this thesis
This thesis is divided into eight chapters. After this introduction and 
problem formulation, Chapter 2 describes the randomised sham-controlled 
double blind multicentre clinical trial to ascertain the effect of percutaneous 
radiofrequency treatment for sacroiliac joint pain. Chapter 3 describes the 
randomised sham-controlled double blind multicentre clinical trial to ascertain 
the effect of percutaneous radiofrequency treatment for lumbar facet joint 
pain. In Chapter 4 the randomised sham-controlled double blind multicentre 
clinical trial to ascertain the effect of percutaneous radiofrequency treatment at 
the ramus communicans for lumbar disc pain is described. Chapter 5 describes 
the inter-rater reliability of the diagnostic criteria for SI joint –, disc – and 
facet joint pain and Chapter 6 discusses the predictive validity of lumbar 
X-ray images and MRIs for chronic LBP subtypes. Chapter 7 describes the 
case series study on the effectiveness of BKP for painful vertebral compression 
fractures. Chapter 8 provides for a general discussion of the main findings, 
strengths and limitations of all studies in this thesis.
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Abstract
Objectives 
To investigate the effect of a percutaneous radiofrequency heat lesion 
compared to a sham procedure, applied to the lateral branches of L5, S1, S2, S3 
and S4 nerve roots.
Methods
Sixty patients aged 18 or more with a medical history and physical 
examination suggestive for sacroiliac joint pain and a reduction of 2 or more 
on a numerical rating scale (NRS, 0-10) after a sacroiliac joint test block. 
Treatment group: percutaneous radiofrequency (RF) heat lesion at the lateral 
branches of S1, S2, S3 and S4 nerve roots and the posterior ramus dorsalis 
of L5; sham group: same procedure as the treatment group except for the 
radiofrequency heat lesion. Primary outcome measure: pain reduction (NRS). 
Secondary outcome measure: Global Perceived Effect (GPE).
Results
No statistically significant difference in pain level over time between the 
groups (Group x Period) (F(1,58)=.353; p=0.56) nor in the factor Group 
(F(1,58)=.212; p=0.65) was found. The Period factor however yielded a significant 
difference (F(1,58)=61.67; p<0.001), i.e. when pooled together the mean pain 
level of the patients was significantly reduced at T1 compared to T0. In the 
crossover group, 42.1% experienced a reduction in NRS of 2 or more at 1 
month (p=0.65). No statistically significant difference in satisfaction over time 
between the groups was found (F(1,50)=2.1; p=0.15). The independent factors 
Group (F(1,50)=2.02; p=0.16) and Period (F(1,50)=0.95; p=0.33) also showed no 
statistically significant difference. The same applies to recovery: no statistically 
significant Group x Period effect (F(1,51)=0.09; p=0.77) was found, neither an 
effect of Group (F(1,51)=0.004; p=0.95) nor of Period (F(1,51)=0.27; p=0.60).
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Discussion
The hypothesis of no difference in pain reduction or in global perceived effect 
between the treatment and sham group cannot be rejected.
Level of evidence
1A.
Key words
Sacroiliac joint, Radiofrequency, RCT, Sham, Chronic pain.
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Introduction
In patients with sacro-iliac (SI) joint pain (constituting 10%-38% of patients 
with chronic low back pain1-3), questions rise concerning the persons who 
might be more susceptible for these problems, how the diagnosis should 
be made and what comprises optimal treatment. For diagnosing SI joint 
problems, besides a suggestive medical history and a physical examination4-8, 
an intra-articular injection with local anaesthetics is still being used. Every 
step has its limitations and the whole diagnostic cascade should lead towards 
sufficient evidence for treatment of the SI joint.
Several types of treatment for trying to diminish SI joint pain are described 
in the literature, one of them is applying radiofrequency (RF) current to the 
nerves that provide the innervation9,10. Several studies describe a success ratio 
between 64% and 80%11-13. The application of RF current can be provided in 
several ways (pulsed or continuous, side of the lesion, number of lesions)3,10,14-17, 
the practicality of the application must always be considered. More recently 
evidence emerged about the use of cooled RF current in providing a significant 
and long lasting pain relief18-23. 
The Simplicity© III probe (Neurotherm®, Wilmington, Massachusetts, United 
States) is a multi-electrode radiofrequency probe that has a unique design 
which allows for positioning using a single percutaneous entry point. With this 
procedure the lateral branches of S1, S2, S3 and S4 are targeted at the same 
time (a L5 dorsal root ramus radiofrequency lesioning is performed separately). 
Up to now, there are no randomized controlled trials available concerning 
the use of this device in diminishing SI joint pain. In this randomised sham-
controlled double-blind multicenter clinical trial (Current Controlled Trials 
ISRCTN45914408) the percutaneous radiofrequency treatment of SI joint 
pain with this probe was evaluated and compared to a sham procedure. A 
crossover was provided for the sham-operated group after three months if no 
significant pain relief was obtained.
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Materials and Methods
Study design
We conducted a randomised sham-controlled double-blind multicenter clinical 
trial in patients with sacroiliac joint pain for more than 3 months. The medical 
ethics committee from Erasmus University Medical Centre approved the 
protocol. Written informed consent was obtained from all participants.
Participants
Suitable patients for the study were recruited from a population of patients 
referred to the multidisciplinary pain centres of two general hospitals with 
complaints of ongoing low back pain for more than 3 months. Conservative 
care (rest, analgesics and physiotherapy) had failed to improve their burden. 
These patients were managed according to the flowchart presented in Figure 
1. When a SI joint problem was suspected (details of medical history, physical 
examination and - if necessary - additional tests4-7 leading, either wholly or in 
part, to the diagnosis of SI joint pain) can be found in table 1), and patients 
met the in- and exclusion criteria24 (table 2), and if the test SI joint injection 
with local anaesthetics was positive (decrease in NRS of 2 or more on a 0-10 
point scale25), the patient was eligible for the RCT. Each patient received 
a general brochure containing information concerning scientific research 
involving human subjects (Ministry of Health, Welfare and Sports26) and a 
brochure (including the questionnaires) explaining the complete procedure. 
After giving written informed consent patients were enrolled in the study.
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Figure 1: Study flowchart. NRS indicates numerical rating scale; RCT, randomized controlled trial; 
RF, radiofrequency.
Study interventions
Test SI joint injection: the injection was performed under fluoroscopy with a 10 
cm Sluijter-Mehta Kit (SMK) needle (Cotop® via Neurotherm®, Wilmington, 
Massachusetts, United States). The patient lies in the prone position on the 
operating table with a pillow under the pelvis. From the anteroposterior (AP) 
view, the c-arm is rotated contralaterally until the medial cortical line of the 
posterior articulation is in focus. Local anesthesia with 1 mL lidocaine 2% 
was given for skin infiltration. Needle insertion is 1-2 cm cranially from the 
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lower border of the SI joint at the level of the zone of maximal radiographic 
translucency. Introduction of the needle into the SI joint is characterized by a 
change in resistance. On a lateral view, the needle tip should appear anterior to 
the dorsal border of the sacrum. The SI joint was injected with a total of 3 mL 
lidocaine 2%. 
RF heat lesion of the ramus dorsalis of L5 and lateral branches of S1, S2, S3 and 
S4 with a RF probe with three independent active electrodes versus sham: when 
patients were candidates for the trial they were randomised in two study 
groups: 
1. Treatment group: monitoring according to American Society of 
Anesthesiologists (ASA) House of Delegates Standards for Basic Anesthetic 
Monitoring27. Continuous intravenous (IV) propofol Target Controlled 
Infusion (TCI) 0,5 µg/mL and remifentanyl 0,05 µg/kg/min. Continuous 
oxygen 15 L/min (non-rebreather mask and bag). The patient lies in the 
prone position on the operating table with a pillow under the pelvis. Skin 
infiltration with 1 mL lidocaine 2% per level. The skin entry point for the RF 
probe with three independent active electrodes is identified at the ipsilateral, 
lateral, inferior border of the sacrum, 1 cm lateral of and below the S4 foramen. 
Infiltration over the course of the RF probe with three independent active 
electrodes with 10 mL lidocaine 2%, staying lateral to the sacral foramen, in 
contact with the sacrum, and medial to the SI joint. Inserting and advancing 
RF probe, maintaining continuous contact with the sacrum, on a cephalad 
and slightly lateral line, staying lateral to the sacral foramen, medial to the SI 
joint and ventral to the ilium, until contact with the sacral ala prevents further 
advancement. Percutaneous RF heat lesion (85o C, each step 90 s, total of 
five steps) with a radiofrequency lesion generator (NT2000, Neurotherm®, 
Wilmington, Massachusetts, United States) at the lateral branches of S1, S2, 
S3 and S4 nerve roots. Percutaneous RF heat lesion (85o C for 90 s, same 
lesion generator) of the L5 dorsal root primary ramus with a 10 cm SMK 
needle, placed to lie in contact with the S1 superior articular process just 
slightly above the groove formed between the superior articular process and 
sacral ala; then advanced with needle position confirmed using fluoroscopy 
(AP and lateral view) and motor stimulation (2 Hz and at least 1 V).
2. Sham-operated group: same procedure as in treatment group except for the 
RF heat lesions.
A crossover was provided for the sham-operated group after three months if 
no significant pain relief was obtained.
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Diagnostic criteria for SI joint pain
Medical history
1. Unilateral pain
2. Patient fingerpoints to the location of the pain
3. Pain produced or increased when rising from sitting
4. Direct trauma to the SI joint
5. Buttock pain while turning over in bed
6. Sitting on opposite buttock
7. Hip feels unstable or has given way, some patients fall
8. Pain radiating into the groin or thigh
9. Sciatica (often S1)
10. Pregnancy, giving birth
Physical examination
1. Sitting exam shows no reflex, motor or sensory signs in the legs
2. Straight leg raising (Lasègue) negative between 30 and 70 degrees of passive flexion
3. Distraction (Gapping) test
4. Compression test
5. Sacral thrust test
6. Posterior shear (thigh thrust) test
7. Pelvic torsion (Gaenslen’s) test
8. Cranial shear test
9. Patrick-Faber test
10. Bilateral internal rotation of the hip / unilateral rotation of the hip painful at SI joint(s)
11. Drop test
12. Yeoman’s test
Additional tests (if available and/or necessary)
1. X-ray pelvis AP
2. CT
3. MRI
4. Diagnostic SI joint block
Table 1: Details about medical history, physical examination and additional tests in patients leading, 
either wholly or in part, to the diagnosis of sacroiliac joint pain4-7.
Outcomes
The main study parameter was pain reduction (Numerical Rating Scale 
(NRS)28-32). The 0–10 verbal numeric rating scale (NRS-11) is a tool that 
enjoys widespread clinical use due to its ease of administration. When using 
the NRS-11 patients are asked to rate their pain on a scale from 0 to 10, 
where 0 represents “no pain” and 10 represents “the worst pain possible,” using 
whole numbers (11 integers including zero). Often the value of “4” is used to 
confirm clinical nursing judgment as to the need for further intervention or 
documentation that the patient’s goals for analgesia have been achieved.
32 CHAPTER 2
Inclusion
1. Age 18 years or older
2. Anamnesis and physical investigation suggestive of SI joint pain
3. Decrease in NRS of 2 or more / 10 on diagnostic SI joint block
Exclusion
1. Presence of red flags28
2. Lumboradicular syndrome
3. Aspecific low back pain
4. Corpus vertebrae problem
5. Progressive neurological defecits
6. Major psychiatric disorder (according to psychiatrists opinion)
7. Anticoagulation cannot be stopped
8. Active infection
9. Pain in other parts of the body that is more severe
10. Allergies to any medication used in the study
11. Pregnancy
12. Communication (language) difficulties (according to physicians opinion)
Table 2: In- and exclusion criteria24 for patients with SI joint pain eligible for RCT.
The secondary study parameter was Global Perceived Effect (GPE)33-35. The 
type of rating of perceived effect is a “transition scale” or Global Perceived 
Effect (GPE) scale. The GPE scale asks the patient to rate, on a numerical 
scale, how much their condition has improved or deteriorated since some 
predefined time point. The GPE has several qualities that make it an appealing 
tool for use in clinical practice and research; being a single question, it is easy 
and quick to administer and the results are seemingly simple to interpret. Such 
scales have been recommended for use as a core outcome measure for chronic 
pain trials and been advocated to increase the relevance of information from 
clinical trials to clinical practice.
Follow-up
The results of the crossover group were analysed separately, and compared 
with those who received the actual treatment in the first case. Time periods 
for follow-up are presented in table 3. Both groups received graded activity36,37 
physiotherapy, which constitutes an individual, submaximal, gradually increased 
exercise program, with an operant-conditioning behavioral approach, based on 
the results of the tests and the demands of the patient’s work.
Statistical considerations
Difference in patients’ gender between the experimental groups was 
analysed using Fisher’s Exact Test. Difference in age was analysed using the 
Independent-Samples Mann-Whitney U test; the difference in BMI using 
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the Independent-Samples T-test. The data on the NRS-11, GPE (subscales 
“Satisfaction” and “Recovery”) were analysed by means of a MANOVA for 
repeated measurements using as independent variables Group (treatment and 
sham) and Time (in case of the NRS-11 Period T0-T1, in case of the GPE 
subscales Period T1-T2 as independent variables).
For the skewed distributed variables we nevertheless decided to use 
MANOVA for repeated measurements analysis of variance. We did so, because, 
although the MANOVA test requires that each dependent variable entered 
into the analysis be normally distributed it can still be used in case of skewly 
distributed dependent variable(s). The Monte Carlo experiments have shown 
that for sample size 3 or 5 it is still possible to analyse leptokurtic, rectangular, 
J-shaped, moderately, and markedly skewed distributions. These experiments 
demonstrated that the empirically determined rejection region of the 
F-distribution would be no larger than α = 0.08 when the usual 5% rejection is 
used38.
The percentage of patients requesting crossover and subsequently reporting 
a significant pain relief was analysed using the One-Sample Binomial Test 
(reference probability 0.5). Only patients in the sham group could switch to 
the intervention.
Period Description
T0 Day of first consultation: medical history, physical examination, 
additional tests if necessary. Excluding red flags28, aspecific low 
back pain and corpus vertebrae problems. Obtaining NRS.
T1 1 month after treatment: NRS and GPE.
T2 3 months after treatment: NRS, GPE.
T1c 1 month after treatment for crossover group: NRS and GPE.
T2c 3 months after treatment for crossover group: NRS, GPE.
Table 3: Time periods for follow-up (NRS: Numerical Rating Scale; GPE: Global Perceived Effect).
The sample size was computed using the NRS-11 as the primary outcome 
parameter. A statistically detectable and clinically relevant within / between 
interaction effect size (f(V)) of 0.2 on this scale was chosen. The power of the 
study (1 – β) was chosen to be 0.8, an allocation ratio of 1:1 and the two-sided 
level of significance (α) to be 0.05. The required a priori total sample size 
computed by this method is 60.
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Data were analysed using SPSS for Mac, version 22 (International Business 
Machines (IBM) Corporation, Software Group, Route 100, Somers, NY, 
10589, United States of America). The primary comparison was done at T1.
Blinding
Based upon the required sample size calculation, sixty envelopes (30 “treatment 
group” and 30 “sham group”) were prepared, sealed, mixed and placed together 
in a box. Patients chose an envelope randomly. Patients as well as their pain 
physicians were completely unaware of the content of the envelope during 
any stage (or T2 in case of sham procedure without reduction in NRS of 2 
or more) of the investigation. The pain research nurse was the only one aware 
of the contents and performed the treatment accordingly. Regarding the 
radiofrequency lesion generator, all sound indicators were turned off and the 
generator itself was visually hidden from the patient by means of a linen cloth, 
hung between two metal infusion poles. The pain physician left the operating 
theatre when the actual treatment (RF current or sham) took place. The same 
time period was taken for an actual – or a sham treatment.
Results
Patients were included and treated between February 2012 and June 2014. 
Out of 79 eligible patients (one patient entered the study without a written 
informed consent) a total of 19 patients resigned due to various reasons: 
no significant pain reduction after diagnostic block (9), no more pain after 
diagnostic block (2), afraid of unemployment (1), not enough time (1), shortly 
after signing the informed consent form, no reason specified (1), second 
opinion (1), cumbersome sedation (1), chronic pain turned bearable (1), fear of 
needles (1) and without reporting a cause (1).
The flowchart of the progress through the phases of the RCT is presented 
in figure 2. The demographic data of the treatment and sham groups are 
presented in table 4. There was no statistically significant difference between 
the parameters of the groups.
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Figure 2: Flow diagram of the progress through the phases of the randomized controlled trial.  
RF indicates radiofrequency.
Parameter Treatment Sham p
Age (years), median, (IQR) 59.5 (27) 62 (18) 0.89
BMI (kg/m2), mean, (sd) 28.1 (5.2) 28 (4.9) 0.87
Male gender (number, %) 5 (16.7) 5 (16.7) 1
Female gender (number, %) 25 (83.3) 25 (83.3) 1
Caucasian race (number, %) 30 (100) 30 (100) 1
Table 4: Demographic data of the treatment - and sham groups (IQR: interquartile range (25,75); sd: 
standard deviation; p: level of significance; BMI: Body Mass Index).
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Outcome
parameter
Treatment 
group mean 
(sd)
Sham group mean 
(sd)
Results MANOVAs
NRS 
T0
7.2 (1.4) 7.5 (1.2) Group
Period
Group x Period
F(1,58)=0.212; p=0.65
F(1,58)=61.76; p<0.001
F(1,58)=0.353; p=0.56NRS 
T1
5.4 (1.7) 5.4 (1.9)
GPE satisfaction 
T1
3.2 (1.1) 3.3 (1.0) Group
Period
Group x Period
F(1,50)=2.02; p=0.16
F(1,50)=0.95; p=0.33
F(1,50)=2.1; p=0.15GPE satisfaction 
T2
3.1 (1.6) 3.8 (1.5)
GPE recovery 
T1
3.3 (1.0) 3.3 (1.0) Group
Period
Group x Period
F(1,50)=0.004; p=0.95
F(1,50)=0.27; p=0.60
F(1,50)=0.09; p=0.77GPE recovery 
T2
3.4 (1.6) 3.4 (1.5)
Table 5: Numerical rating scale (NRS) and global perceived effect (GPE) scales of the treatment - and 
sham groups (sd: standard deviation; T0: Day of first consultation; T1: 1 month after treatment; T2:  
3 months after treatment).
No statistically significant difference in pain level over time between the 
groups (Group x Period) (F(1,58)=.353; p=0.56) nor in the factor Group 
(F(1,58)=.212; p=0.65) was found. The Period factor however yielded a significant 
difference (F(1,58)=61.67; p<0.001), i.e. when pooled together the mean pain 
level of the patients was significantly reduced at T1 compared to T0 (figure 3). 
In the crossover group, 8 out of 19 patients experienced a reduction in NRS of 
2 or more at 1 month crossover (p=0.65). 
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Figure 3: Boxplot of numerical rating scale (NRS)-11 scores by group and by moment of measurement 
(verum=treatment group; falsus=sham group).
No statistically significant difference in satisfaction over time between the 
groups (Group x Period) was found (F(1,50)=2.1; p=0.15). The independent 
factors Group (F(1,50)=2.02; p=0.16) and Period (F(1,50)=0.95; p=0.33) also 
showed no statistically significant difference (eight missing cases on T2). The 
same applies to recovery: no statistically significant Group x Period effect 
(F(1,51)=0.09; p=0.77) was found, neither an effect of Group (F(1,51)=0.004; 
p=0.95) nor of Period (F(1,51)=0.27; p=0.60) (seven missing cases on T2) (table 
5).
During the trial we noted one unexpected and unsuspected serious adverse 
event, due to a fall from the stairs during the follow up period.
Discussion
In this randomised controlled trial the proportion of patients who reported 
a significant pain relief (NRS ≥ 2) after the sham procedure was even higher 
(but not statistically significant) than those after the actual treatment. In the 
crossover group (3 months after the sham procedure) the number of people 
that demonstrated a statistically significant reduction after the RF treatment 
was 42.1%, which equals the number of positive results (43.3%) from the 
primary treatment group. 
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The number of positive SI joint test blocks was 86.1% (62 out of 72 blocks), which 
is higher than expected when considering the available literature1,2,8 on the subject. 
Possible reasons could be (the combination of ) multidisciplinary assessment, rating 
of the decrease in NRS as a result of the test injection with local anaesthetics 
according to Ostelo et al. (positive test injection with local anaesthetics when a 
decrease in NRS of 2 or more on a 0-10 point scale is obtained)25 instead of a 
decrease of 50% in NRS, using only local anesthetics instead of corticosteroids and 
the probability that, based on the diagnostic cascade used, the patients did not have 
SI joint pain. The false-positive rate of a single, uncontrolled, SI joint injection with 
local anaesthetics is around 20%2, but can be a high as 54%1. The local anaesthetic 
diffuses out of the joint in 61% of cases, becoming an intra- as well as extra-
articular injection12. 
The presence of pain distal to the knee in patients with SI joint pain is described 
but not often found and SI joint denervation often won’t relieve this type of 
pain when present. Instead of using “sciatica (often S1)” as inclusion criterion 
it would have been better to use “pain predominantly below L5”. As stated the 
whole diagnostic cascade should be taken into account and not a single item. 
Another limitation of this study is the fact that we used only one diagnostic test 
block instead of using a double diagnostic test block. Having considered the daily 
practice in pain management, this sham RCT was completed with one diagnostic 
test block.  
Regarding the internal validity of this study: (1) Due to the anatomy of the sacrum, 
we sometimes didn’t reach the S4 branch with the radiofrequency probe with three 
independent active electrodes, performing a L5 to S3 radiofrequency procedure. 
How much does the S4 branch attributes to SI joint pain? The size of the lesion 
by the radiofrequency probe with three independent active electrodes might be 
smaller than the one from the cooled RF treatment variant39 but, again, what is the 
(exact) influence of that? (2) Age was nonnormally (bimodally) distributed (figure 
3); this might reflect differences in disease type, encompassing different structures 
(anatomical changes, disorders of the capsuloligamentous structures, and diastasis 
from pregnancy and childbirth and disorders from the vascular plexus or complex 
neural network) and operative procedures1,5; (3) Pain scores were measured during 
follow-up at specific time periods (table 3). Using average pain scores over certain 
time periods (i.e. past month), based on pain diaries might have led to a different 
result; (4) All patients received graded activity36-37 physiotherapy, but not at a 
single centre; as a consequence gaining evidence of equal quality of physiotherapy 
accompaniment was difficult and we therefore do not know whether – and if so to 
which extend – this factor has confounded the treatment outcome.
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On the basis of this RCT the hypothesis of no difference in pain reduction or in 
global perceived effect between the treatment and sham group cannot be rejected 
(level of evidence 1A40).
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Abstract
Aims
The aim of this study was to compare the effect of a percutaneous 
radiofrequency heat lesion at the medial branch of the primary dorsal ramus 
with a sham procedure, for the treatment of lumbar facet joint pain.
Patients and Methods
A randomised sham-controlled double blind multicentre trial was carried out 
at the multidisciplinary pain centres of two hospitals. A total of 60 patients 
aged > 18 years with a history and physical examination suggestive of facet 
joint pain and a decrease of ≥ 2 on a numerical rating scale (NRS 0 to 10) 
after a diagnostic facet joint test block were included. In the treatment group, 
a percutaneous radiofrequency heat lesion (80oC during 60 seconds per level) 
was applied to the medial branch of the primary dorsal ramus. In the sham 
group, the same procedure was undertaken without for the radiofrequency 
lesion. Both groups also received a graded activity physiotherapy programme. 
The primary outcome measure was decrease in pain. A secondary outcome 
measure was the Global Perceived Effect scale (GPE).
Results
There was a statistically significant effect on the level of pain in the factor 
Period (T0-T1). However, there was no statistically significant difference with 
the passage of time between the groups (Group x Period) or in the factor 
Group. In the crossover group, 11 of 19 patients had a decrease in NRS of 
≥ 2 at one month crossover (p = 0.65). There was no statistically significant 
difference in satisfaction with the passage of time between the groups (Group x 
Period). The independent factors Group and Period also showed no statistically 
significant difference. There was no statistically significant Group x Period 
effect for recovery, neither an effect of Group or of Period.
Conclusion
The null hypothesis of no difference in the decrease in pain and in GPE 
between the treatment and sham groups cannot be rejected. Post hoc analysis 
revealed that the age of the patients and the severity of the initial pain 
significantly predicted a positive outcome.
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Introduction
In 1911 Goldthwait1 proposed that in patients with chronic low back pain 
(LBP), the facet joints were a potential source of pain. Several reviews have 
subsequently described difficulties in diagnosing facet joint pain,2-4 when 
based on the medical history, physical examination and radiological findings. 
However, in 1976, Mooney and Robertson described the injection of local 
anaesthetic in an attempt to confirm the diagnosis.5 Recently, radiofrequency 
has been described as a possible form of treatment for lumbar facet joint pain.6 
Radiofrequency causes the localised destruction of neural tissue
and interruption of neural signaling. This is known as the radiofrequency heat 
lesion.6 Fluoroscopically guided percutaneous radiofrequency denervation of 
the lumbar facet joints have been associated with an overall incidence of minor 
complications of 1% per lesion site such as ongoing localised pain or
neuritic pain and no major complications have been reported.7 
Recently two systematic reviews addressed radiofrequency treatment for 
patients with LBP. Leggett et al.8 analysed six sham-controlled randomised 
control trials (RCTs) involving lumbar facet joint pain, performed between 
1994 and 2008. There were many differences between the trials including the 
duration of LBP before the patients entered the study, which was between 
three months and more than two years, and which specialty performed the 
examination. Also there were variations in the exclusion criteria, such as 
previous spinal surgery in three RCTs and previous radiofrequency
treatment in one. They reported differences in the way the diagnostic blocks 
were performed, how the results were interpreted, the number of treatments 
given and of patients entered into the trial. Poetscher et al.9 evaluated nine 
RCTs comparing the effect of radiofrequency treatment with
other forms of treatment and with a placebo and found that radiofrequency 
denervation was more effective than a placebo and steroid injections. They 
concluded, however, that the evidence should be interpreted with caution. 
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Fig 1. Study flowchart (NRS, Numerical Rating Scale; RCT, Randomised Clinical Trial; RF, Radio 
Frequency).
In a review article dealing with the treatment of facet joint pain, Cohen, 
Huang and Brummett10 described even more differences in these various 
studies. The results of these RCTs are therefore inconsistent and do not resolve 
the debate about the role of radiofrequency treatment in chronic LBP. 
In an attempt to answer these issues, a randomised sham-controlled 
double blind multicentre clinical trial (RCT; Current Controlled Trials 
ISRCTN17868852) was constructed. Its aim was to investigate the effect of 
a percutaneous radiofrequency heat lesion compared with a sham procedure, 
when applied to the medial branch of the primary dorsal ramus, for treatment 
of lumbar facet joint pain. The effect on the intensity of pain and on perceived 
effectiveness of this treatment was compared with a sham procedure.  
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A crossover was provided for the sham-operated group after a minimum of 
three months if no significant pain relief was reported. The null hypothesis was 
that there was no difference in the reduction of pain or in Global Perceived 
Effect (GPE) scale between the two groups.
Period Description
T0 Day of first consultation: medical history, physical examination, 
additional tests if necessary. Excluding red flags28, nonspecific 
low back pain and corpus vertebrae problems. Obtaining NRS.
T1 1 month after treatment: NRS and GPE.
T2 3 months after treatment: NRS, GPE.
T1c 1 month after treatment for crossover group: NRS and GPE.
T2c 3 months after treatment for crossover group: NRS, GPE.
Table I: time periods for follow-up (NRS: Numerical Rating Scale; GPE: Global Perceived Effect).
Patients and Methods
The Erasmus University Medical Centre Rotterdam ethical committee, which 
is approved by the Dutch Central Committee on Research Involving Human 
Subjects, and the local hospital both approved the protocol. All patients gave 
written informed consent.
Patients were recruited from those with a history of LBP for more than 
three months, who had been referred to the multidisciplinary pain centres 
of Lievenberg Hospital, Bergen op Zoom, The Netherlands and Franciscus 
Hospital, Roosendaal, The Netherlands. Conservative care which
included rest, analgesics and physiotherapy had failed to improve the pain. 
These patients were managed as shown in Figure 1. The medical history and 
clinical findings were recorded, along with radiographs, CT and MRI scans. 
The inclusion and exclusion criteria were based on the New
Zealand LBP Guide.11 A test injection at the medial branch of the primary 
dorsal ramus with local anaesthesia was performed and if it induced a decrease 
in the Numerical Rating Scale (NRS) for pain of ≥ 2 on a 0 to 10 point scale,12 
the patient was eligible for inclusion. Each patient then received a brochure 
containing general information about research involving humans (Ministry 
of Health, Welfare and Sports)13 and one, including the questionnaires, 
explaining the procedure.
51
RANDOMISED SHAM-CONTROLLED DOUBLE BLIND MULTICENTRE CLINICAL TRIAL TO ASCERTAIN 
THE EFFECT OF PERCUTANEOUS RADIOFREQUENCY TREATMENT FOR LUMBAR FACET JOINT PAIN
The test injection at the medial branch of the primary dorsal ramus was 
performed under fluoroscopy with three 10 cm Sluijter-Mehta Kit needles 
(Cotop via Neurotherm, Wilmington, Massachusetts) at the facet joint that 
was presumed to be the source of the pain and into the two adjacent levels. 
For the L5/S1 level, the adjacent L4/L5 level was also treated. The patient 
lay prone on the operating table with a pillow under the abdomen in order to 
flatten the lumbar lordosis. From the anteroposterior (AP) view, the C-arm 
was rotated obliquely to the ipsilateral side so that the junction between the 
superior articular process and the transverse process was more easily accessible. 
Local anaesthesia with 1 mL lidocaine 2% per level was infiltrated into the 
skin. Contact was made with the transverse process as close as possible to the 
superior articular process. After contacting bone, the needle was advanced 
slightly in a cranial direction so that its tip slid over the transverse process. In 
the lateral view, the tip of the electrode lay at the base of the superior articular 
process at the lower aspect of the intervertebral foramen, approximately 1 
mm dorsal to its posterior border. After sensory (50 Hz) - and motor (2 Hz) 
stimulation with contraction of the ipsilateral multifidus muscle and excluding 
too close proximity to the segmental nerve, a total of 0.5 mL lidocaine 2% was 
introduced around each medial branch. 
The patients were randomised into two groups:
1) Treatment group: the same procedure as the test was used except that a 
percutaneous radiofrequency heat lesion (80ºC for 60 seconds per level, total of 
three steps) was given with a radiofrequency generator (NT2000,  
Neurotherm)® into the medial branches of the primary dorsal ramus; 
2) sham group: the same procedure as in treatment group was used except 
without the radiofrequency heat lesions.
A crossover for the sham group was provided after a minimum of three 
months if no significant pain relief (without a decrease in NRS for pain of ≥ 2) 
was obtained.
The main outcome was a decrease in pain using the NRS-1114-18. When using 
this scale, patients are asked to rate their pain from 0 to 10, where 0 represents 
“no pain” and 10 represents “the worst pain possible”, using whole numbers 
(11 integers including zero). The secondary outcome was the GPE scale,19-21 
for which the patient is asked to rate, numerically, how much their condition 
has improved or deteriorated from some predefined time point. The test-retest 
reliability of the GPE scale is excellent,19-21 but the ratings are influenced by 
the current status of the patient.
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The results of the crossover group were analysed separately and compared with 
those who received the actual treatment initially. The periods of time at which 
the patients were reviewed are shown in Table I.
The patients in both groups were also treated with graded activity 
physiotherapy22,23, containing an individual, submaximal, gradually increasing 
exercise programme and an operant-conditioning behavioural approach. This is 
based on the results of the tests and the demands of the patient’s work. 
Fig. 2 Flow diagram of the progress through the randomized controlled trial (RF, radiofrequency).
Statistical analysis
The differences in gender, age and body mass index (BMI) between the groups 
were analysed using Fisher’s exact test, the Mann-Whitney U test and the 
independent samples t-test, respectively. The data on the NRS-11 and GPE 
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(subscales “Satisfaction” and “Recovery”) were analysed using multivariate 
analysis of variance (MANOVA) for repeated measurements using, as 
independent variables, Group (treatment versus sham) and Time (with the 
NRS-11 Period T0-T1, and the GPE subscales Period T1-T2).
We also used MANOVA for repeated measurements analysis of variance for 
the variables whose distribution was skewed. We did this, because, although 
the MANOVA test requires that each dependent variable entered into the 
analysis be normally distributed, it can still be used for variables whose 
distribution is skewed. The Monte Carlo experiments24-26 have shown that for 
sample size three or five it is still possible to analyse leptokurtic (clustering 
along the x-axis with higher peak), rectangular, J-shaped, moderately, and 
markedly skewed distributions. These experiments showed that the empirically 
determined rejection region of the F-distribution would be < α = 0.08 when 
the usual 5% rejection is used.
The percentage of patients requesting crossover and subsequently reporting 
significant pain relief was analysed using the one-sample binomial test 
(reference probability 0.5). Only patients in the sham group could switch to 
the intervention.
The required a priori sample size for the trial was computed using the NRS-
11 as the primary outcome measure. A statistically detectable and clinically 
relevant with/between interaction effect size (f(V)) of 0.2 on the scale was 
chosen. The power of the study (1 - β) was chosen to be 0.8, an allocation ratio 
of 1:1 and the two-sided level of significance (α) 0.05. The required sample size 
was 60.
Data were analysed using SPSS for Mac, version 22 (International Business 
Machines (IBM) Corporation, Software Group, Route 100, Somers,  
New York). The primary comparison was done at T1, which was one month 
after the treatment.
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Parameter Treatment Sham p
Age (years), median, (IQR) 65 (12) 58 (12) 0.004
BMI (kg/m2), mean, (sd) 29.7 (4.7) 29.4 (5.9) 0.42
Male gender (number, %) 14 (46.7) 12 (40)
Female gender (number, %) 16 (53.3) 18 (60) 
Caucasian race (number, %) 30 (100) 30 (100)
Table II: demographic data of the treatment - and sham groups (IQR: interquartile range (25,75); sd: 
standard deviation; p: level of significance; BMI: Body Mass Index).
Outcome
parameter
Treatment  
group mean (sd)
Sham  
group mean (sd)
Results MANOVAs
NRS 
T0
7.2 (1.4) 7.4 (0.8) Group
Period
Group x Period
F(1,58)=0.194; p=0.66
F(1,58)=39.95; p<0.001
F(1,58)=0.393; p=0.53NRS 
T1
5.3 (1.8) 5.5 (1.9)
GPE satisfaction 
T1
3.4 (1.0) 3.5 (1.2) Group
Period
Group x Period
F(1,51)=0.445; p=0.51
F(1,51)=0.40; p=0.53
F(1,51)=1.23; p=0.27GPE satisfaction 
T2
3.4 (1.0) 3.7 (1.3)
GPE recovery 
T1
3.3 (1.0) 3.4 (1.2) Group
Period
Group x Period
F(1,52)=0.456; p=0.50
F(1,52)=0.80; p=0.38
F(1,52)=0.09; p=0.77GPE recovery  
T2
3.4 (1.0) 3.6 (1.1)
Table III: numerical rating scale (NRS) and global perceived effect (GPE) scales of the treatment - and 
sham groups (sd: standard deviation; T0: Day of first consultation; T1: 1 month after treatment; T2: 3 
months after treatment).
Experimental group
Duration (yrs) Treatment 
n (%)
Sham 
n (%)
< 0,5 4 (13.3) 5 (16.7)
0,5-1 2 (6.7) 6 (20)
1-5 10 (33.3) 10 (33.3)
>5 13 (43.3) 6 (20)
Unknown 1 (3.3) 3 (10)
Total 30 (100) 30 (100)
Table IV: duration of low back pain before entering the study by group (T0).
Based on the calculation of the sample size, 60 envelopes (30 for each  
group, treatment and sham) were prepared, sealed, mixed and placed in a  
box. Patients chose an envelope randomly. Patients and physicians were 
unaware of the content of the envelope at all stages of the investigation. 
55
RANDOMISED SHAM-CONTROLLED DOUBLE BLIND MULTICENTRE CLINICAL TRIAL TO ASCERTAIN 
THE EFFECT OF PERCUTANEOUS RADIOFREQUENCY TREATMENT FOR LUMBAR FACET JOINT PAIN
The pain research nurse (F. Schuurmans) was the only one aware of the 
contents and arranged the treatment accordingly. All sound indicators of the 
radiofrequency lesion generator were turned off and the generator itself was 
hidden from the patient by means of a linen cloth, hung between two infusion 
poles. The pain physician left the operating theatre when the actual treatment 
(radiofrequency or sham) took place. The same time period was taken for 
an actual or a sham treatment. In this way the physicians, investigators and 
patients were blinded for the intervention. At time periods T1 and T2, the 
patient was asked by the physician and or the investigator to rate the pain and 
the recovery, the research nurse played no part here.
Results
The trial took place between February 2012 and June 2014. Out of 104 eligible 
patients, 44 withdrew for a variety of reasons: no significant decrease in pain 
after the diagnostic test (22), increased pain after the diagnostic test (one), not 
enough time (three), family reasons (three), alternative treatment (one), chronic 
pain which became bearable (one), fear of needles (one), painful procedure 
despite local anaesthesia (three), comorbidity (three) and without reporting  
a reason (six).
Progress through the trial is shown in Figure 2. The demographic data of the 
patients in both groups are shown in Table II. The age distribution was skewed 
but other parameters were normally distributed.
A statistically significant effect on the level of pain of the factor Period (T0-
T1) was found. However, there was no statistically significant difference with 
the passage of time between the groups (Group x Period) nor in the factor 
Group. In the crossover group, 11 of 19 patients had a decrease in the NRS 
of ≥ 2 at one month crossover (p = 0.65). There was no statistically significant 
difference with the passage of time in satisfaction between the groups (Group x 
Period). The independent factors Group and Period also showed no statistically 
significant difference. The same applied to recovery, no statistically significant 
Group x Period effect was found, neither an effect of Group
nor of Period (Table III).
The duration of LBP before entering the study (T0) for the patients is shown 
in Table IV and the description of the relative frequency of severity of the LBP 
is shown in Table V, with the patients’ age in Table VI. 
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NRS Treatment frequency (%) Sham frequency (%)
1 0 (0) 0 (0)
2 0 (0) 0 (0)
3 0 (0) 0 (0)
4 2 (6.7) 0 (0)
5 2 (6.7) 0 (0)
6 3 (10) 3 (10)
7 11 (36.7) 13 (43.3)
8 8 (26.7) 13 (43.3)
9 4 (13.3) 1 (3.3)
10 0 (0) 0 (0)
Table V: (relative) frequency distribution of severity of low back pain before entering the study (T0).
Fig. 3 Size of the decrease in pain due to the diagnostic test (%) compared with the rate of success of the 
intervention (%).
A total of 50 patients (83.3%) had a decrease of > 50% after the diagnostic 
test. Post hoc, the validity (in terms of sensitivity) of the percentage decrease in 
pain after the diagnostic test, in predicting the percentage which would have a 
decrease after the intervention at T1 (treatment or sham), was analysed. There 
was no statistically significant correlation between these parameters, neither 
in the treatment (r = 0.003; p = 0.99) nor sham group (r = 0.16; p = 0.40). The 
size of the decrease in pain due to the diagnostic test did not seem to influence 
the rate of success of the intervention (Fig. 3).
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A total of 29 patients (48.3%) reported a significant decrease in pain (by NRS 
of ≥ 2). Our analysis showed that these patients cannot be predicted by the 
interventional procedure (treatment or sham). In order to evaluate the possible 
contribution of other parameters than the intervention to the prediction of a 
significant decrease in pain at T1, binary logistical regression analysis was used. 
The parameters entered into this analysis were gender, BMI, duration of 
symptoms, the level of pain at baseline, age and the interaction between group 
and age (Group x Age) because of the imbalance in age between the groups. In 
order to prevent overfitting of the model, univariate binary logistic regression 
analysis of these parameters was performed. Only age and the level of pain at 
T0, the parameters with a level of significance of p ≤ 0.2, were entered into the 
final multivariate stepwise binary logistic regression analysis (Backward Wald 
method) with a probability of p = 0.1. This analysis revealed that age (p = 0.01) 
and the initial level of pain (p = 0.08) significantly contributed to
the prediction of a significant decrease in pain (Table VII). This resulted in a 
sensitivity of 62.1%, a specificity of 67.7% (overall classification 65%), with a 
cutoff value of 0.5, being a moderate performance.
No serious adverse events were encountered during the trial.
Discussion
In 2003, following a critical review, Slipman et al.27 emphasised the need 
for RCTs to provide recommendations on the treatment of facet joint pain, 
because of the moderate to limited evidence available. Recent systematic 
reviews have identified six randomised, placebo-controlled trials investigating 
the efficacy of the radiofrequency lesion on the medial branch of the primary 
dorsal ramus.8-10 Among these, three small studies were positive28-30, two were 
equivocally positive,31 and one32 was negative10. The overall quality of the 
evidence of the studies was low to moderate.
Lack of concealment of allocation and failure to blind patients was reported 
in several trials, and the risk of selective reporting in all trials9. The number of 
positive lumbar facet joint test blocks was 77.8% (81 of 104). Several studies 
reported a high percentage of false positive blocks33-36 due to reasons such 
as placebo response, sedation, the liberal use of superficial local anaesthesia, 
spread of the injected material to pain generating structures other than those 
targeted and using only local anaesthetics instead of including corticosteroids. 
Furthermore, the combination of multidisciplinary treatment and the criteria 
chosen for the diagnostic test to be called positive differ between studies 
(decrease in NRS of ≥ 2,12,50% or 80%37 pain relief ). 
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A limitation of our study is the use of one instead of two test blocks, which 
was chosen because it is our pain management practice. Also pain scores were 
measured during follow-up at specific moments in time. Using mean pain 
scores over certain periods of time, for example the past month, and based on 
pain diaries might lead to a different result. Depending on the median duration 
of the symptoms, decrease in pain is unlikely to be due to spontaneous 
recovery. In addition, the regression analysis revealed no statistically significant 
effect of the interaction of group and age. Therefore, a possible overall effect 
of treatment due to the imbalance in age between the two groups, is unlikely. 
The injection of local anaesthetics is a different procedure than inducing a 
radiofrequency heat lesion. When the heat lesion does not lead to a significant 
decrease in pain, does that mean that the diagnostic block is a false positive? 
Or does it mean that the treatment cannot provide significant decrease in pain, 
contrary to the diagnostic test? Another limitation is that we did not test the 
patients for the success of blinding. However, since the results of the crossover, 
when the patients knew that they would receive the real radiofrequency heat 
lesion, were comparable, we do not think this compromised the results.
Age
(yrs)
Treatment n (%) Sham 
n (%)
30-39 0 (0) 2 (6.7)
40-49 2 (6.7) 5 (16.7)
50-59 5 (16.7) 11 (36.7)
60-69 15 (50) 9 (30)
70-79 8 (26.7) 3 10)
Total 30 (100) 30 (100)
Table VI: patients’ age before entering the study by group.
95% CI for Odds Ratio
B (SE) [p-value] Lower Odds Ratio Upper
Included
   Constant 1.6 (3.15) [.61]
   Age -0.09 (.035) [.01] .85 0.914 0.98
Pain level at baseline    0.53 (.3) [.08] .94 1.69 3.03
Table VII: results of multivariate binary logictic regression analysis (R2=0.21 (Cox & Schnell), 0.28 
(Nagelkerke). Model X2(2)=14.32, p=0.001).
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All patients had physiotherapy, but not at a single centre, and as a consequence 
we do not know if and to what extent this factor confounded the outcome. 
Whilst 11 of 19 patients in the crossover group had a clinically but not 
statistically significant decrease in pain at T1 (p = 0.65), this would support the 
results from the primary analysis. Post hoc analysis revealed that age and the 
initial severity of pain significantly predicted a positive outcome.
In conclusion, following this RCT we are unable to reject the null hypothesis, 
of no difference in either decrease in pain or in the GPE scale between the 
treatment and sham groups when using radiofrequency for lumbar facet  
joint pain.
Supplementary material
Tables showing details about medical history, physical examination and 
additional tests in patients with facet joint pain (Table 1) and inclusion/
exclusion criteria for patients with facet joint pain eligible for  
RCT (Table 2).
Diagnostic criteria for facet joint pain
Medical history
1. Age > 65 years
2. Trauma (fall, auto accident)
3. Dull and deep ache
4. Localised unilateral or bilateral back pain
5. Low back pain associated with groin or thigh pain
6. Pain, if referred to the leg, is above the knee
7. Unilateral or bilateral muscle spasm over the affected joints
8. Pain not exacerbated by coughing
9. Pain relief by recumbency
10. Lack of radicular features
Physical examination
1. Pain in extension
2. Pain eased in flexion
3. Pain when rising from forward flexion
4. Pain in extension, lateral flexion or rotation manoeuvers to the ipsilateral side
5. Replication or aggravation of pain by unilateral or bilateral pressure over the facet joints or transverse process
6. Local unilateral or bilateral passive movements show reduced range of motion or increased stiffness on the side of facet 
joint pain
7. Tight or facilitated muscles (psoas, hip adductors, hamstring muscles)
8. Weak or inhibited muscles (gluteus maximus, gluteus medius muscles)
Additional tests (if available and/or necessary)
1. X-ray lumbar spine AP / lateral
2. CT
3. MRI
4. Diagnostic medial branch block
Table 1: details about medical history, physical examination and additional tests in patients with facet 
joint pain.
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Inclusion
1. Age 18 years or older
2. Medical history and physical examination suggestive of facet joint pain
3. Decrease in NRS of 2 or more / 10 on diagnostic medial branch block
Exclusion
1. Presence of red flags22
2. Lumboradicular syndrome
3. Aspecific low back pain
4. Corpus vertebrae problem
5. Progressive neurological defecits
6. Major psychiatric disorder (according to psychiatrists opinion)
7. Anticoagulation cannot be stopped
8. Active infection
9. Pain in other parts of the body that is more severe
10. Allergies to any medication used in the study
11. Pregnancy
12. Communication (language) difficulties (according to physicians opinion)
Table 2: in- and exclusion criteria for patients with facet joint pain eligible for RCT.
References
1. Goldthwait JE. The lumbosacral articulation: an explanation of many cases of lumbago, sciatica, and 
paraplegia. Boston Med Surg J 1911;164:365-372.
2. Datta S, Lee M, Falco FJ, Bryce DA, Hayek SM. Systematic assessment of diagnostic accuracy and 
therapeutic utility of lumbar facet joint interventions. Pain Physician 2009;12:437-460.
3. Manchikanti L, Pampati S, Cash KA. Making sense of the accuracy of diagnostic lumbar facet joint 
nerve blocks: an assessment of the implication of 50% relief, 80% relief, single block, or controlled 
diagnostic blocks. Pain Physician 2010;13:133-143.
4. Hancock MJ, Maher CG, Latimer J, et al. Systematic review of tests to identify the disc, SIJ or facet 
joint as the source of low back pain. Eur Spine J 2007;16:1539-1550.
5. Mooney V, Robertson J. The facet syndrome. Clin Orthop 1976;115:149-156.
6. Erdine S, Bilir A, Cosman ER, Cosman ER Jr. Ultrastructural changes in axons following exposure to 
pulsed radiofrequency field. Pain Practice 2009;9:407-417.
7. Kornick C, Kramarich SS, Lamer TJ, Todd Sitzman B. Complications of lumbar facet radiofrequency 
denervation. Spine 2004;29:1352-1354.
8. Leggett LE, Soril LJJ, Lorenzetti DL, et al. Radiofrequency ablation for chronic low back pain: a 
systematic review of randomized controlled trials. Pain Res Manag 2014;19:e146-e153.
9. Poetscher AW, Gentil AF, Lenza M, Ferretti M. Radiofrequency denervation for facet joint low back 
pain: a systematic review. Spine (Phila Pa 1976) 2014;39:e842-e849.
10. Cohen SP, Huang JHY, Brummett C. Facet joint pain – advances in patient selection and treatment. 
Nat Rev Rheumatol 2013;9:101-116.
11. ACC. New Zealand Low Back Pain Guide. http://www.acc.co.nz/PRD_EXT_CSMP/groups/
external_communications/documents/guide/prd_ctrb112930.pdf (date last accessed 8 August 2016).
12. Ostelo RWJG, Deyo RA, Stratford P, et al. Interpreting change scores for pain and functional status 
in low back pain - towards international consensus regarding minimal important change. Spine (Phila 
Pa 1976) 2008;33:90-94.
13. No authors listed. Ministry of Health, Welfare and Sports: Medisch-Wetenschappelijk Onderzoek. 
http://www.rijksoverheid.nl/documenten-en-publicaties/brochures/2008/10/02/medisch-
wetenschappelijk-onderzoek.html (date last accessed 8 August 2016).
14. Breivik EK, Bjornsson GA, Skovlund E. A comparison of pain rating scales by sampling from clinical 
trial data. Clin J Pain 2000; 16: 22-28.
15. Grotle M, Brox JI, Vollestad NK. Concurrent comparison of responsiveness in pain and functional 
status meaurement used for patients with low back pain. Spine (Phila Pa 1976) 2004;29:E492-E501.
61
RANDOMISED SHAM-CONTROLLED DOUBLE BLIND MULTICENTRE CLINICAL TRIAL TO ASCERTAIN 
THE EFFECT OF PERCUTANEOUS RADIOFREQUENCY TREATMENT FOR LUMBAR FACET JOINT PAIN
16. Van der Roer N, Ostelo RW, Bekkering GE, van Tulder MW, de Vet HC. Minimal clinically 
important change for pain intensity, funtional status, and general health status in patients with 
nonspecific low back pain. Spine (Phila Pa 1976) 2006;31:578-582.
17. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in 
chronic pain intensity measured on a 11-point numerical pain rating scale. Pain 2001;94:149-158.
18. Childs JD, Piva SR, Fritz JM. Responsiveness of the numeric pain rating scale in patients with low 
back pain. Spine 2005;30:1331-1334.
19. Kamper SJ, Ostelo RWJG, Knol DL, et al. Global Perceived Effect scales provided reliable 
assessments of health transition in people with musculoskeletal disorders, but ratings are strongly 
influenced by current status. J Clin Epidemiol 2010;63:760-766.
20. Dworkin RH, Turk DC, Farrar JT, et al; IMMPACT. Core outcome measures for chronic pain 
clinical trials: IMMPACT recommendations. Pain 2005;113:9-19.
21. Fischer D, Stewart AL, Bloch DA, et al. Capturing the patient’s view of change as a clinical outcome 
measure. JAMA 1999;282:1157-1162.
22. Lindstrom I, Ohlund C, Eek C, et al. The effect of graded activity on patients with subacute low back 
pain: a randomized prospective clinical study with an operant-conditioning behavioral approach. Phys 
Ther 1992;72:279-290.
23. Staal JB, Hlobil H, Twisk JW, et al. Graded activity for low back pain in occupational health care: a 
randomized, controlled trial. Ann Intern Med 2004;140:77-84.
24. Slipman CW, Bhat AL, Gilchrist RV, et al. A critical review of the evidence for the use of 
zygapophysial injections and radiofrequency denervation in the treatment of low back pain. Spine J 
2003;3:310-316.
25. Leclaire R, Fortin L, Lambert R, Bergeron YM, Rossignol M. Radiofrequency facet joint 
denervation in the treatment of low back pain: a placebo-controlled clinical trial to assess efficacy. Spine 
(Phila Pa 1976) 2001;26:1411-1416.
26. van Wijk RM, Geurts JW, Wynne HJ, et al. Radiofrequency denervation of lumbar facet joints in the 
treatment of chronic low back pain: a randomized, double-blind, sham lesion-controlled trial. Clin J 
Pain 2005;21:335-344.
27. van Kleef M, Barendse GA, Kessels A, et al. Randomized trial of radiofrequency lumbar facet 
denervation for chronic low back pain. Spine (Phila Pa 1976) 1999;24:1937-1942.
28. Nath S, Nath CA, Pettersson K. Percutaneous Lumbar Zygapophysial (Facet) joint neurotomy using 
radiofrequent current, in the management of chronic low back pain: A randomized double-blind trial. 
Spine (Phila Pa 1976) 2008;33:1291-1297.
29. Tekin I, Mirzai H, Ok G, Erbuyun K, Vatansever D. A comparison of conventional and pulsed 
radiofrequency denervation in the treatment of chronic facet joint pain. Clin J Pain 2007;23:524-529.
30. Cohen SP, Raja SN. Pathogenesis, diagnosis, and treatment of lumbar zygapophysial (facet) joint pain. 
Anesthesiology 2007;106:591-614.
31. Datta S, Lee M, Falco FJ, Bryce DA, Hayek SM. Systematic assessment of diagnostic accuracy and 
therapeutic utility of lumbar facet joint interventions. Pain Physician 2009;12:437-460.
32. Falco FJ, Erhart S, Wargo BW, et al. Systematic review of diagnostic utility and therapeutic 
effectiveness of cervical facet joint interventions. Pain Physician 2009;12:323-344.
33. Schwarzer AC, Aprill CN, Derby R, et al. The false positive rate of uncontrolled diagnostic blocks of 
the lumbar zygapophysial joints. Pain 1994;58:195-200.
34. Yelland MJ, Schluter PJ. Defining worthwhile and desired responses to treatment of chronic low back 
pain. Pain Med 2006;7:38-45.
62 CHAPTER 3
Chapter 
4
Randomized sham-controlled 
double-blind multicenter clinical 
trial on the effect of percutaneous 
radiofrequency at the ramus 
communicans for lumbar disc pain
van Tilburg CW, Schuurmans FA, Stronks DL, Groeneweg JG, Huygen FJ
Eur J Pain 2017;21:520-9
DOI 10.1002/ejp.945
64 CHAPTER 4
65
RANDOMIZED SHAM-CONTROLLED DOUBLE-BLIND MULTICENTER CLINICAL TRIAL ON THE EFFECT 
OF PERCUTANEOUS RADIOFREQUENCY AT THE RAMUS COMMUNICANS FOR LUMBAR DISC PAIN
Abstract
Background 
Investigate the effect of percutaneous radiofrequency compared to a sham 
procedure, applied to the ramus communicans for treatment of lumbar disc 
pain.
Methods
Randomized sham-controlled double blind crossover multicenter clinical trial. 
Multidisciplinary pain centers of two general hospitals. Sixty patients aged 18 
or more with medical history and physical examination suggestive for lumbar 
disc pain and a reduction of 2 or more on a numerical rating scale (0-10) after 
a diagnostic ramus communicans test block. Treatment group: percutaneous 
radiofrequency treatment applied to the ramus communicans; sham: same 
procedure except radiofrequency treatment. Primary outcome measure: pain 
reduction. Secondary outcome measure: Global Perceived Effect.
Results
No statistically significant difference in pain level over time between the 
groups, as well as in the group was found; however, the factor period yielded 
a statistically significant result. In the crossover group, 11 out of 16 patients 
experienced a reduction in NRS of 2 or more at 1 month (no significant 
deviation from chance). No statistically significant difference in satisfaction 
over time between the groups was found. The independent factors group and 
period also showed no statistically significant effects. The same applies to 
recovery: no statistically significant effects were found.
Conclusions
The null hypothesis of no difference in pain reduction and in global perceived 
effect between the treatment and sham group cannot be rejected. Post-hoc 
analysis revealed that none of the investigated parameters contributed to the 
prediction of a significant pain reduction.
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Introduction
In patients with chronic low back pain, the discs represent a potential pain 
generator1-3. Disc pain can occur as a result of genetic implications, together 
with degenerative marks and start at an early age4-8. Low back disc pain uses 
the sympathetic nervous system; pain impulses coming from the intervertebral 
disc join the L2 spinal ganglion via the rami communicantes and the 
sympathetic trunk9-10. In patients with chronic lumbar disc pain, symptoms 
can show no improvement over time11. One of the treatment possibilities is 
applying high frequency energy at specific sites in or around the lumbar discs. 
Applying radiofrequency (RF) is a possible, but not generally accepted option 
for chronic low back pain. When a continuous radiofrequency (CRF) current 
is used, the tissue heating can lead to localized destruction of neural tissue and 
consequent interruption of neural signaling12.
Interrupting signalling through the ramus communicans may interfere with 
the transition of painful information from the discs to the central nervous 
system13. To evaluate the efficacy of a RF treatment at the ramus communicans, 
a few studies were performed14-15. Methodological differences exist in these 
studies concerning the inclusion criteria, outcome parameters and follow-up. In 
a systematic review addressing RF treatment for low back pain subtypes, three 
sham-controlled RCT’s involving lumbar disc pain16 were included; differences 
between the studies were observed regarding RF technique, duration of low 
back pain before entering the study, the exclusion criteria and the number of 
participants. The results of these studies are inconsistent and do not help to 
settle the continuing debate about the role of this specific treatment in chronic 
lumbar disc pain.
Therefore, we set up a randomized sham-controlled double blind multicenter 
clinical trial (Current Controlled Trials ISRCTN48011364). The aim of the 
study is to investigate the effect of a percutaneous RF treatment compared 
to a sham procedure, applied at the ramus communicans; we investigated the 
effect on pain intensity and on global perceived effect of this interventional 
treatment compared to a sham procedure. A crossover was provided for the 
sham-operated group after a minimum of three months if no significant pain 
relief was reported.
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Methods
Study design
We conducted a randomized sham-controlled double blind multicenter clinical 
trial in patients with lumbar disc pain for more than 3 months. The medical 
ethics committee from Erasmus University Medical Center approved the 
protocol. Written informed consent was obtained from all participants.
Participants
Suitable patients for the study were recruited from a population of patients 
with complaints of ongoing low back pain for more than 3 months and 
referred to the multidisciplinary pain centers of Lievensberg Hospital 
(Bergen op Zoom, The Netherlands) or Franciscus Hospital (Roosendaal, 
The Netherlands). Conservative care (rest, analgesics and physiotherapy) had 
failed to improve their burden. These patients were managed according to the 
flowchart presented in Fig. 1. When a disc problem was suspected (table 1) and 
patients met the in- and exclusion criteria17 (table 2), and if the test injection 
at the ramus communicans with local anesthetics was positive (decrease in 
Numerical Rating Scale (NRS) of 2 or more on a 0-10 point scale18), the 
patient was eligible for the RCT. Each patient received a general brochure 
containing information concerning scientific research involving human 
subjects (Ministry of Health, Welfare and Sports19) and a brochure (including 
the questionnaires) explaining the complete procedure. After giving written 
informed consent patients were enrolled in the study.
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Figure 1: Study flowchart.
Diagnostic criteria for disc pain
Medical history
1. Centralization of pain
2. Pain when rising from sitting
3. Low back pain, worse after prolonged sitting, flexion, coughing, sneezing
4. Referred pain to the groin, buttock and thigh
5. Chronic muscle imbalance patterns
6. Repeated episodes of low back pain (onset may be sudden or may result from overuse or unidentified causes)
7. Fear or be unable to flex during the episodes
Physical examination
1. Gait deviation
2. Abnormal sensory and motor examination, hyperactive or diminished reflexes
3. Digital interspinous pressure (DIP) test positive
4. Straight leg raising (Lasègue) positive between 30 and 70 degrees of passive flexion
Additional tests (if available and/or necessary)
1. CT (degeneration)
2. MRI (degeneration)
3. Diagnostic block at ramus communicans
Table 1: details about medical history, physical examination and additional tests in patients with  
disc pain.
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Inclusion
1. Age 18 years or older
2. Medical history and physical examination suggestive of lumbar disc pain
3. Decrease in NRS of 2 or more / 10 on diagnostic ramus communicans block
Exclusion
1. Presence of red flags15
2. Lumboradicular syndrome
3. Aspecific low back pain
4. Corpus vertebrae problem
5. Progressive neurological defecits
6. Major psychiatric disorder (according to psychiatrists opinion)
7. Anticoagulation cannot be stopped
8. Active infection
9. Pain in other parts of the body that is more severe
10. Allergies to any medication used in the study
11. Pregnancy
12. Communication (language) difficulties (according to physicians opinion)
Table 2: in- and exclusion criteria for patients with disc pain eligible for RCT.
Study interventions
Test injection at the ramus communicans: the injection was performed under 
fluoroscopy with 15 cm Sluijter-Mehta Kit (SMK) needles (Cotop® via 
Neurotherm®, Wilmington, Massachusetts, United States). The patient lies prone 
on the operating table with a pillow under the abdomen to flatten the lumbar 
lordosis. From the anteroposterior (AP) view, the c-arm is rotated obliquely to the 
ipsilateral side so that facet joints are projected away and the vertebral column is 
clearly visible. From the sagittal plane, the c-arm is rotated to let the transverse 
process change its location relative to the vertebral body and, as a result, the axis 
of the transverse process lies slightly above the middle of the vertebral body. The 
injection point is marked just caudally to the transverse process and somewhat 
medially to the lateral border of the vertebral body. Local anesthesia with 1 mL 
lidocaine 2% was given for skin infiltration. The needle is advanced until contact is 
made with the vertebral body. On the lateral view, the tip of the needle should be 
somewhat ventral to the posterior side of the lateral body. After sensory (50 Hz) 
and motor (2 Hz) stimulation as an adjunct to confirm correct needle placement, 
the ramus communicans was surrounded with a total of 0.5 mL lidocaine 2%.
RF treatment at the ramus communicans versus sham: when patients were candidates 
for the trial they were randomized in two study groups: 
1. Treatment group: treatment was performed under under fluoroscopy with 15 
cm Sluijter-Mehta Kit (SMK) needles (Cotop® via Neurotherm®, Wilmington, 
Massachusetts, United States). The patient lies prone on the operating table 
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with a pillow under the abdomen to flatten the lumbar lordosis. From the 
anteroposterior (AP) view, the c-arm is rotated obliquely to the ipsilateral 
side so that facet joints are projected away and the vertebral column is clearly 
visible. From the sagittal plane, the c-arm is rotated to let the transverse 
process change its location relative to the vertebral body and, as a result, the 
axis of the transverse process lies slightly above the middle of the vertebral 
body. The injection point is marked just caudally to the transverse process and 
somewhat medially to the lateral border of the vertebral body. Local anesthesia 
with 1 mL lidocaine 2% was given for skin infiltration. The needle is advanced 
until contact is made with the vertebral body. On the lateral view, the tip of 
the needle should be somewhat ventral to the posterior side of the lateral body. 
After sensory (50 Hz) and motor (2 Hz) stimulation, the ramus communicans 
was surrounded with a total of 0.5 mL lidocaine 2% and a RF treatment (80o 
C during 60 s per level) with a radiofrequency lesion generator (NT2000, 
Neurotherm®, Wilmington, Massachusetts, United States) was carried out;
2. Sham-operated group: same procedure as in the treatment group except for 
the RF treatment.
A crossover was provided for the sham-operated group after three months if 
no significant pain relief was obtained.
Both groups received graded activity20,21 physiotherapy, which constitutes of an 
individual, submaximal, gradually increased exercise program, with an operant-
conditioning behavioral approach, based on the results of the tests and the 
demands of the patient’s work.
Outcome parameters
The primary study parameter was pain reduction (NRS22-26). The 0–10 verbal 
numeric rating scale (NRS-11) is a tool that enjoys widespread clinical use 
due to its ease of administration. When using the NRS-11 patients are asked 
to rate their pain on a scale from 0 to 10, where 0 represents “no pain” and 
10 represents “the worst pain possible,” using whole numbers (11 integers 
including zero). Often the value of “4” is used to confirm clinical nursing 
judgment as to the need for further intervention or documentation that the 
patient’s goals for analgesia have been achieved.
The secondary study parameter was Global Perceived Effect (GPE)27-29. The 
type of rating of perceived effect is a “transition scale”. This numerical scale 
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asks the patient to rate how much their condition has improved or deteriorated 
since some predefined time point. The GPE has several qualities that make 
it an appealing tool for use in clinical practice and research; being a single 
question, it is easy and quick to administer and the results are simple to 
interpret. This scale is recommended for use as a core outcome measure for 
chronic pain trials and advocated to increase the relevance of information from 
clinical trials to clinical practice.
Follow-up
The results of the crossover group were analyzed separately. Time periods for 
follow-up are presented in table 3.
Statistical considerations
The Kolmogorov-Smirnov test was used to analyze whether or not parameters 
were normally distributed. Difference in patients’ gender between the 
experimental groups was analyzed using Fisher’s Exact Test. Difference in age 
and in BMI was analyzed using the Independent-Samples T-test. The data 
on NRS-11, GPE (subscales “Satisfaction” and “Recovery”) were analyzed by 
means of a MANOVA for repeated measurements using independent variables 
Group (treatment or sham) and Time (in case of the NRS-11 Period T0-T1, 
in case of the GPE subscales Period T1 and T2 as independent variables). 
For the skewed distributed variables we nevertheless decided to use 
MANOVA for repeated measurements analysis of variance. We did so, 
because, although the MANOVA test requires that each dependent variable 
entered into the analysis be normally distributed it can still be used in case 
of skewly distributed dependent variable(s). The Monte Carlo experiments30 
have shown that for sample size 3 or 5 it is still possible to analyze leptokurtic, 
rectangular, J-shaped, moderately, and markedly skewed distributions. These 
experiments demonstrated that the empirically determined rejection region of 
the F-distribution would be no larger than α=0.08 when the usual 5% rejection 
is used.
The percentage of patients requesting crossover and subsequently reporting 
a significant pain relief was analysed using the One-Sample Binomial Test 
(reference probability 0.5). Only patients in the sham group could switch to 
the intervention.
The required a priori sample size was computed using the NRS-11 as the 
primary outcome parameter. A statistically detectable and clinically relevant 
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with / between interaction effect size (f(V)) of 0.2 on the scale was chosen. The 
power of the study (1 - β) was chosen to be 0.8, an allocation ratio of 1:1 and 
the two-sided level of significance (α) 0.05. The required a priori total sample 
size computed by this method is 60.
Data were analyzed using SPSS for Mac, version 22 (International Business 
Machines (IBM) Corporation, Software Group, Route 100, Somers, NY, 
10589, United States of America). The primary comparison was done at T1.
Period Description
T0 Day of first consultation: medical history, physical examination, 
additional tests if necessary. Excluding red flags28, aspecific low 
back pain and corpus vertebrae problems. Obtaining NRS.
T1 1 month after treatment: NRS and GPE.
T2 3 months after treatment: NRS, GPE.
T1c 1 month after treatment for crossover group: NRS and GPE.
T2c 3 months after treatment for crossover group: NRS, GPE.
Table 3: time periods for follow-up (NRS: Numerical Rating Scale; GPE: Global Perceived Effect).
Blinding
Based upon the required sample size calculation, sixty envelopes (30 “treatment 
group” and 30 “sham group”) were prepared, sealed, mixed and placed together 
in a box. Patients chose an envelope randomly. Patients as well as their pain 
physicians were completely unaware of the content of the envelope during 
any stage of the investigation. The pain research nurse was the only one 
aware of the contents and performed the treatment accordingly. Regarding 
the radiofrequency generator, all sound indicators were turned off and the 
generator itself was visually hidden from the patient by means of a linen cloth, 
hung between two metal infusion poles. The pain physician left the operating 
theatre when the actual treatment (RF current or sham) took place. The same 
time period was taken for an actual – or a sham treatment.
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Results
Patients were included and treated between March 2012 and December 2014. 
Out of 116 eligible patients a total of 56 patients resigned due to various 
reasons: no significant pain reduction after diagnostic block (33), not enough 
time (2), communication problems (4), chronic pain turned bearable (2), 
painful needle insertion procedure despite local anesthetics (3), technique not 
possible (1), comorbidity (4), pregnancy (1) and without reporting a cause (6).
The flowchart of the progress through the phases of the RCT is presented in 
Fig. 2. The demographic data of the treatment and sham groups are presented 
in table 4. There were no statistically significant differences in the parameters 
between both groups.
Figure 2: Flow diagram of the progress through the phases of the RCT.
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No statistically significant difference in pain level over time between the 
groups (Group x Period) (F(1,58)=0.04; p=.84), nor in the factor Group 
(F(1,58)=0.01; p=.92) was found; however, the factor Period yielded a statistically 
significant result (F(1,58)=40.68; p<.001) (table 5). In the crossover group, 11 
out of 16 patients experienced a reduction in NRS of 2 or more at 1 month 
crossover (p=.21).
No statistically significant difference in satisfaction over time between the 
groups (Group x Period) was found (F(1,46)=0.95; p=.34). The independent 
factors Group (F(1,46)=0.80; p=.38) and Period (F(1,46)=0.002; p=.97) also 
showed no statistically significant difference. The same applies to recovery: no 
statistically significant Group x Period effect (F(1,46)=0.33; p=.57) was found, 
neither an effect of Group (F(1,46)=0.02; p=.89) nor of Period (F(1,46)=2.43; 
p=.13) (table 5).
The duration of low back pain before entering the study (T0) in the treatment 
– and sham groups of this RCT is presented in table 6; the same applies to the 
description of the relative frequency distribution of severity of low back pain 
(table 7) and patients’ age (table 8).
During the trial we noted no serious adverse events.
Parameter Treatment Sham p
Age (years), mean, (sd) 50.5 (13.9) 50.1 (12.3) .91
BMI (kg/m2), mean, (sd) 27.8 (4.3) 27.8 (4.0) .67
Male gender (number, %) 10 (33.3) 11 (36.7) 1
Caucasian race (number, %) 30 (100) 30 (100) 1
Table 4: Demographic data of the verum - and sham groups (sd: standard deviation; p: level of 
significance; BMI: Body Mass Index).
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Outcome
parameter
Treatment  
group mean (sd)
Sham  
group mean (sd)
Results MANOVAs
NRS 
T0
7.8 (1.05) 7.8 (1.05) Group
Period
Group x Period
F(1,58)=0.01; p=.92
F(1,58)=40.68; p<.001
F(1,58)=0.04; p=.84NRS 
T1
5.8 (2.28) 5.7 (2.28)
GPE satisfaction 
T1
3.5 (1.92) 3.7 (1.84) Group
Period
Group x Period
F(1,46)=0.80; p=.38
F(1,46)=0.002; p=.97
F(1,46)=0.95; p=.34GPE satisfaction 
T2
3.3 (2.09) 3.8 (2.02)
GPE recovery 
T1
3.7 (1.48) 3.6 (1.43) Group
Period
Group x Period
F(1,46)=0.02; p=.89
F(1,46)=2.43; p=.13
F(1,46)=0.33; p=.57GPE recovery 
T2
3.4 (1.77) 3.5 (1.70)
Table 5: numerical rating scale (NRS) and global perceived effect (GPE) scales of the treatment - and 
sham groups (sd: standard deviation; T0: Day of first consultation; T1: 1 month after treatment; T2: 3 
months after treatment).
Duration (yrs) Treatment group
n (%)
Sham 
group
n (%)
> 0.25 / < 0,5 4 3
0,5-1 3 1
1-5 11 11
>5 12 15
Unknown 0 0
Total 30 (100) 30 (100)
Table 6: duration of low back pain before entering the study by group (T0).
NRS Treatment frequency (%) Sham frequency (%)
£ 4 0 (0) 0 (0)
5 1 (3.33) 1 (3.33)
6 3 (10) 2 (6.67)
7 3 (10) 8 (26.67)
8 18 (60) 12 (40)
9 5 (16.67) 5 (16.67)
10 0 (0) 2 (6.67)
Table 7: (relative) frequency distribution of severity of low back pain before entering the study (NRS: 
Numerical Rating Scale).
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Age
(years)
Treatment group
n (%)
Sham group
n (%)
18-29 2 (6.67) 3 (10)
30-39 5 (16.67) 3 (10)
40-49 5 (16.67) 9 (30)
50-59 13 (43.33) 6 (20)
60-69 2 (6.67) 9 (30)
70-79 3 (10) 0 (0)
Total 30 (100) 30 (100)
Table 8: patients’ age before entering the study by group.
Discussion
In this randomized, sham-controlled, double blind, multicenter RCT we have 
investigated the effect of a percutaneous RF treatment compared to a sham 
procedure, applied to the ramus communicans for treatment of lumbar disc 
pain. This study does not support this type of treatment; we cannot reject the 
null hypothesis of no difference in pain reduction or in global perceived effect 
between the treatment and sham group. In the crossover group, 11 of out 
of 16 patients experienced a clinically significant pain reduction at T1. This 
proportion is not statistically significant from chance (p=.21); this finding 
supports the results from the primary analysis, where we also did not find a 
statistically significant result from the treatment intervention compared to the 
sham intervention. 
Considerations with respect to our findings: firstly, this RCT has possible 
methodological limitations: 1) having considered daily practice in pain 
management, we used one diagnostic test block; 2) pain scores were measured 
during follow-up at specific moments in time. Using average pain scores over 
certain time periods (e.g. past month), based on pain diaries might have led to 
a different result; 3) the injection of local anesthetics is a different procedure 
compared to a RF treatment. So, when the RF treatment does not lead to a 
significant pain reduction, does that mean that the diagnostic test block was an 
invalid predictor of the effect of a RF treatment (i.c. a false positive)? If so, one 
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might wonder how many false negative results of the diagnostic block there 
(also) may have been. We are comparing different procedures with each other, 
with a diagnostic instrument being hard to validate; 4) all patients received 
graded activity28-29 physiotherapy, but not at a single center; as a consequence 
gaining evidence of equal quality of physiotherapy accompaniment was 
difficult and we therefore do not know if – and if so to which extent – this 
factor has confounded the treatment outcome.
It is difficult to compare our results to those of previous studies on this 
subject16 because of the many differences regarding 1) the RF technique used 
(intra-discal, cooled RF trans-discal biacuplasty, intra-annular discTRODE 
probe); 2) the duration of low back pain before entering the study (more than 
6 months to more than 1 year); 3) the exclusion criteria and the number of 
participants. For example, in one study the sham procedure was not the same 
as the actual RF treatment31. Besides using a different anatomical structure by 
Kapural et al., a positive response to diagnostic discography was used instead 
of a decrease in NRS of 2 or more from a diagnostic test block at the ramus 
communicans as an inclusion parameter, like we did in our study. Furthermore 
5) the criterion for a clinically relevant reduction in pain (after the diagnostic 
block and after the intervention) differed between the studies already 
performed. Use was made of a decrease in NRS of 2 or more20, 50% pain relief, 
or 80% pain relief.
In our RCT 48 out of 60 patients experienced a reduction in NRS of 50% or 
more after the diagnostic test block. Post hoc the predictive validity (in terms 
of sensitivity) of the amount of pain reduction after the diagnostic block in 
predicting the effectiveness of the intervention (in terms of the amount of 
pain reduction) after the intervention at T1 (sham or verum) was analyzed. No 
statistically significant correlation between these parameters was found, neither 
in the sham group (r=0.02; p=.93), nor in the verum group (r=-0.27; p=.14). 
So, in terms of predictive sensitivity, the size of the pain reduction after the 
diagnostic test block appears not to be related to the size of the pain reduction 
after the intervention (Fig. 3).
In addition, 6) the pain reduction over time of the patients pooled together, 
might have been due to spontaneous recovery. However, based upon the 
median duration of the complaints of the participating patients spontaneous 
recovery is not likely.
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Keeping the above mentioned difference in mind, two other RCT’s on this 
topic found no statistically significant effect either, and one RCT31 found a 
statistically significant improvement in physical function, pain and disability. 
In their systematic review on non-operative management for discogenic 
back pain32, Lu et al. mention the study from Oh and Shim14 as the only one 
targeting the ramus communicans. The RF treatment used in this study was the 
same as in our study; however, patients were eligible for this RCT only when 
their pain continued after intradiscal electrothermal annuloplasty (IDET). 
The diagnostic test block used had to generate a 50% pain reduction and not a 
decrease in NRS with 2 or more, as was our criterion for a clinical relevant pain 
reduction. Furthermore, the questionnaires used were different, as well as the 
number of participants.
In our RCT 34 out of 60 patients reported a significant decrease in pain of 2 
or more on verbal NRS for pain. Analysis so far revealed that those patients 
cannot be predicted by the interventional procedure. In order to evaluate the 
possible contribution of other parameters than the interventional procedure to 
the prediction of a significant pain reduction at T1, post hoc a binary logistic 
regression analysis was performed (Backward Wald method). The parameters 
to be entered into this analysis were age, gender, BMI and the level of pain at 
baseline. To prevent over fitting of the model, we performed univariate binary 
logistic regression analysis of these parameters. This analysis revealed that none 
of the investigated parameters contributed to the prediction of a significant 
pain reduction.
A comprehensive understanding of spinal innervation is needed for the clinical 
evaluation of lumbar spinal pain. Any component that receives innervation can 
theoretically act as a source of pain33. The sinuvertebral nerves that innervate 
the lumbar discs are formed by a somatic root from a ventral ramus and an 
autonomic root from a grey ramus communicans; an ascending branch passes 
as far as the next higher intervertebral disc, while a descending branch supplies 
the disc at the level of entry. Two types of rami communicantes are observed, 
a superior oblique ramus and a deep transverse ramus34; sinuvertebral nerves 
originate from the deep transverse rami. These deep transverse rami run 
close to the vertebral bodies and along the lumbar arteries and veins; they 
run along the lateral side of each lumbar vertebral body and connect to the 
corresponding lumbar spinal nerve and sympathetic trunk in a segmental 
manner. All superficial oblique rami run upon the surface of the aponeurosis, 
while the deep transverse rami run beneath the aponeurosis. In this way, using 
fluoroscopic guidance, together with sensory – and motor stimulation, we have 
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tried to interrupt the pain impulses with high frequency energy at the site of 
origin.
Figure 3: Comparison of the pain reduction (%) after the diagnostic block and the pain reduction at T1 
after the RF or sham intervention (%).
Neural branches supplying the spinal column can arise from 1) the 
sympathetic trunk directly, 2) the superficial oblique rami, deep transverse 
rami, sinuvertebral nerves and splanchnic nerves and 3) directly from 
each lumbar vertebral primary ramus. Two types of innervation co-exist, a 
segmental (directly from the spinal nerve) and a non-segmental type (via the 
sympathetic nervous system). Discogenic low back pain occurs via visceral 
sympathetic afferents mainly through the L2 spinal nerve root35. Unilateral 
infiltration of this L2 nerve root was not predictive of provocative discography 
results; bilateral infiltration was not investigated36. In patients with L3 and 
L4 vertebral body fractures, L2 spinal nerve block was effective for two 
weeks37. The results from a prospective analysis on the assessment of pulsed 
radiofrequency treatment at the L2 dorsal root ganglion for providing pain 
relief in patients with chronic low back pain with or without lower limb pain 
showed that the procedure is safe and effective for treating chronic low back 
pain38. Targeting the L2 nerve root can possibly be used as a diagnostic tool 
and treatment opportunity35,39, requiring further scientific research.
a b
c
80 CHAPTER 4
References
1. Schwarzer AC, Aprill CN, Derby R, et al. The prevalence and clinical features of internal disc 
disruption in patients with chronic low back pain. Spine 1995;20:1878-83.
2. Pang WW, Mok MS, Lin ML, et al. Application of spinal pain mapping in the diagnosis of low back 
pain - analysis of 104 cases. Acta Anasthesiol Sin 1998;36:71-4.
3. Manchikanti L, Singh V, Pampati V, et al. Evaluation of the relative contributions of various 
structures in chronic low back pain. Pain Physician 2001;4:308-16.
4. Rajasekaran S, Babu JN, Arun R, et al. ISSLS prize winner: A study of diffusion in human lumbar 
discs: A serial magnetic resonance imaging study documenting the influence of the endplate on 
diffusion in normal and degenerate discs. Spine 2004;29:2654-67.
5. Boos N, Weissbach S, Rohrbach H, et al. Classification of age-related changes in lumbar 
intervertebral discs: 2002 Volvo Award in basic science. Spine 2002;27:2631-44.
6. Helm II S, Hayek SM, Benyamin R, et al. systematic review of the effectiveness of thermal annular 
procedures in treating discogenic low back pain. Pain Physician 2009;12:207-32.
7. Hurri H, Karppinen J. Discogenic pain. Pain 2004;112:225-8.
8. Zhang Y, Guo T, Guo X, et al. Clinical diagnosis for discogenic low back pain. Int J Biol Sci 
2009;5:647-58.
9. Raoul S, Faure A, Robert R, et al. Role of the sinu-vertebral nerve in low back pain and anatomical 
basis of therapeutic implications. Surg Radiol Anat 2003;24:366-71.
10. Groen GJ, Baljet B, Drukker J. Nerves and nerve plexuses of the hum vertebral column. Am J Anat 
1990;188:282-96.
11. Peng BG, Pang XD, Li DM, et al. Natural history and prognosis of discogenic low back pain. 
Zhonghua Yi Xue Zhi 2009;89:2171-4.
12. Erdine S, Bilir A, Cosman ER, Cosman ER Jr. Ultrastructural changes in axons following exposure to 
pulsed radiofrequency field. Pain Practice 2009;9:407-17.
13. Zhou Y, Abdi S. Diagnosis and minimally invasive treatment of lumbar discogenic pain - a review of 
the literature. Clin J Pain 2006;22:468-81.
14. Oh WS, Shim JC. A randomized, controlled trial of radiofrequency denervation of the ramus 
communicans nerve for chronic discognic low back pain. Clin J Pain 2004;20:55-60.
15. Levin JH. prospective, double-blind, randomized placebo-controlled clinical trials in interventional 
spine: what the highest quality literature tells us. Spine J 2009;9:690-703.
16. Leggett LE, Soril LJJ, Lorenzetti DL, et al. Radiofrequency ablation for chronic low back pain: a 
systematic review of randomized controlled trials. Pain Res Manag 2014;19:e146-53.
17. No authors listed. New Zealand Low Back Pain Guide. Accident Rehabilitation and Compensation 
Insurance Corporation of New Zealand and the National Health Committee. Wellington, 1997.
18. Ostelo RWJG, Deyo RA, Stratford P, et al. Interpreting change scores for pain and functional 
status in low back pain - towards international consensus regarding minimal important change. Spine 
2008;33:90-4.
19. No authos listed. Ministry of Health, Welfare and Sports: Medisch-Wetenschappelijk Onderzoek. 
Available at http://www.rijksoverheid.nl/documenten-en-publicaties/brochures/2008/10/02/medisch-
wetenschappelijk-onderzoek.html
20. Lindstrom I, Ohlund C, Eek C, et al. The effect of graded activity on patients with subacute low back 
pain: a randomized prospective clinical study with an operant-conditioning behavioral approach. Phys 
Ther 1992;72:279-93.
21. Staal JB, Hlobil H, Twisk JW, Smid T, Köke AJ, van Mechelen W. Graded activity for low back pain 
in occupational health care: a randomized, controlled trial. Ann Intern Med 2004;140:77-84.
22. Breivik EK, Bjornsson GA, Skovlund E. A comparison of pain rating scales by sampling from clinical 
trial data. Clin J Pain 2000; 16: 22–8.
23. Grotle M, Brox JI, Vollestad NK. Concurrent comparison of responsiveness in pain and functional 
status meaurement used for patients with low back pain. Spine 2004;29:E492-E501.
24. Van der Roer N, Ostelo RW, Bekkering GE. Minimal clinically important change for pain 
intensity, funtional status, and general health status in patients with nonspecific low back pain. Spine 
2006;31:578-82.
81
RANDOMIZED SHAM-CONTROLLED DOUBLE-BLIND MULTICENTER CLINICAL TRIAL ON THE EFFECT 
OF PERCUTANEOUS RADIOFREQUENCY AT THE RAMUS COMMUNICANS FOR LUMBAR DISC PAIN
25. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in 
chronic pain intensity measured on a 11-point numerical pain rating scale. Pain 2001;94:149-58.
26. Childs JD, Piva SR, Fritz JM. Responsiveness of the numeric pain rating scale in patients with low 
back pain. Spine 2005;30:1331-4.
27. Kamper SJ, Ostelo RWJG, Knol DL, Maher CG, de Vet HC, Hancock MJ. Global Perceived Effect 
scales provided reliable assessments of health transition in people with musculoskeletal disorders, but 
ratings are strongely influenced by current status. J Clin Epidemiol 2010;63:760-6.
28. Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pain clinical trials: 
IMMPACT recommendations. Pain 2005;113:9-19.
29. Fischer D, Stewart AL, Bloch DA, Lorig K, Laurent D, Holman H. Capturing the patient’s view of 
change as a clinical outcome measure. J Am Med Assoc 1999;282:1157-62.
30. Keppel G. Design and Analysis. A Researchers Handbook. Englewood Cliffs, New Yersey: Prentice 
Hall Inc; 1973.
31. Kapural L, Vrooman B, Sarwar S, et al. A randomized, placebo-controlled trial of transdiscal 
radiofrequency, biacuplasty for treatment of discogenic lower back pain. Pain Med 2013;14:362-73.
32. Lu Y, Guzman JZ, Purmessur D, Iatridis JC, Hecht AC, Qureshi SA, Cho SK. Non-operative 
management for discogenic back pain: a systematic review. Spine 2014;39:1314-24.
33. Bogduk N. The innervation of the vertebral column. Austr J Physiother 1985;31:89-94.
34. Higuchi K, Sato T. Anatomical study of lumbar spine innervation. Folia Morphol 2002;61:71-9.
35. Nakamura S-I, Takahashi K, Takahashi Y, Yamagata M, Moriya H. The afferent pathways of 
discogenic low-back pain. J Bone Joint Surg 1996;78-B:606-12.
36. Mendez R, Bailey S, Paine G, Mazzilli M, Stedje-Larsen E, Nance B, Dietrick K. Evaluation of 
the L2 spinal nerve root infiltration as a diagnostic tool for discogenic low back pain. Pain Physician 
2005;8:55-9.
37. Ohtori S, Yamashita M, Inoue G, et al. L2 spinal nerve-block effects on acute low back pain from 
osteoporotic vertebral fracture. J Pain 2009;10:870-5.
38. Tsou HK, Chao SC, Wang CJ, et al. Percutaneous pulsed radiofrequency applied to the L2 dorsal root 
ganglion for treatment of chronic low back pain: 3-year experience. J Neurosurg Spine 2010;12:190-6.
39. Lim H-W, Cho Y-H, Kim S-H, Lee D-H, Kang S-H. The effectiveness of L2 nerve root block for the 
management of patients who are suffering from chronic low back and referred pain. Korean J Anesthesiol 
2013;65:182-3.
82 CHAPTER 4
Chapter 
5
Inter-rater reliability of diagnostic 
criteria for sacroiliac joint-, disc- 
and facet joint pain
van Tilburg CW, Groeneweg JG, Stronks DL, Huygen FJ
J Back Musculoskelet Rehabil 2017;30:551-7
DOI 10.3233/BMR-150495
84 CHAPTER 5
85
INTER-RATER RELIABILITY OF DIAGNOSTIC CRITERIA FOR 
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Abstract
Background / Objective
Several diagnostic criteria sets are described in the literature to identify low 
back pain subtypes, but very little is known about the inter-rater reliability of 
these criteria. We conducted a study to determine the reliability of diagnostic 
tests that point towards SI joint –, disc – or facet joint pain.
Methods
Inter-rater reliability study alongside three randomized clinical trials. 
Multidisciplinary pain center of general hospital. Patients aged 18 or more 
with medical history and physical examination suggestive of sacroiliac joint 
–, disc – and facet joint pain on lumbar level. Making use of nowadays 
most common used diagnostic criteria, a physical examination is taken 
independently by three physicians (two pain physicians and one orthopedic 
surgeon). Inter-rater reliability (Kappa (k) measure of agreement) and 
significance (p) between raters are presented. Strengths of agreement, indicated 
with k values above 0.20, are presented in order of agreement.
Results
One hundred patients were included. None of the parameters from the 
physical investigation had k values of more than 0.21 (fair) in all pairs of raters. 
Between two raters (C and D), there was an almost perfect agreement on 
three parameters, more specifically “Abnormal sensory and motor examination, 
hyperactive or diminished reflexes”, “Sitting exam shows no reflex, motor 
or sensory signs in the legs” and “Straight leg raising (Laségue) negative 
between 30 and 70 degrees of flexion”. The “Drop test positive” parameters 
had moderate strength of agreement between raters A and D and fair strength 
between raters A and B. The “Digital interspinous pressure test positive” had 
moderate strength of agreement between raters C and D and fair strength 
of agreement between raters A and B as well as raters B and C. Three other 
parameters had a fair strength of agreement between two raters, all other 
parameters had a slight or poor strength of agreement. Inter-rater reliability, 
confidence intervals and significance of pooled items for SI joint -, disc – and 
facet joint pain are represented; k values for the pooled parameters of the 
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physical examination suggestive of SI joint pain stayed below 0.20 between all 
raters. The same applies for the pooled parameters of the physical examination 
suggestive of facet joint – or disc pain.
Conclusions
The poor reliability of the diagnostic parameters seriously limits their 
predictive validity, and as such their use in patients with low back pain for 
more than 3 months.
Keywords
Reliability and validity, Reliability of results, Diagnostic equipment, Low back 
pain, Sacroiliac joint, Facet joint
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Background
The assessment and interpretation of tests used to diagnose low back pain 
subtypes are often not standardized; however, this is necessary for the testing 
to be both valid and reliable1. Until now little is known about the inter-rater 
reliability of these diagnostic criteria. Regarding the diagnostic criteria, Young 
et al. demonstrated that pain when rising from sitting, as well as centralization 
of pain was associated with discogenic pain and that absence of pain when 
rising from sitting was associated with facet joint pain; sacroiliac (SI) joint pain 
was associated with three or more positive pain provocation tests, pain when 
rising from sitting, unilateral pain and absence of lumbar pain2. In a systematic 
review to determine the diagnostic accuracy of tests available to clinicians to 
identify the source of low back pain, Hancock et al. found that centralization 
was the only clinical feature to increase the likelihood of the disc as being 
the source of pain, while absence of degeneration on MRI decreased this 
likelihood. A combination of SI joint tests was informative, single tests not3.
Methods
We conducted an inter-rater reliability study in patients aged 18 years or more 
with low back pain for more than 3 months, who were referred to the pain 
center of a general hospital. The guidelines for reporting of studies of reliability 
and agreement (GRRAS4) were followed. 
Patients with a suspicion of having a spine related pain disorder on lumbar 
level who met the inclusion – (age ≥ 18 years, chronic (> 3 months) low 
back pain) and exclusion (presence of red flags, progressive neurological 
deficits, major psychiatric disorder (according to psychiatrists opinion), pain 
in other parts of the body that is more severe, pregnancy, active infection, 
communication (language) difficulties (according to physicians opinion)) 
criteria were eligible for inclusion. A total of three pain physicians and 
one orthopedic surgeon participated in the trial. The examination for each 
individual patient was performed by a combination of two pain physicians 
and one orthopedic surgeon. The consultations took place within a period 
of two weeks to decrease the chance for confounding and jointly determine 
the cause of the pain problem. A training session was held before the study 
to ensure as much consistency as possible of methods and standardization 
of test procedures, during which every item from the list with diagnostic 
criteria were judged on their presence or absence (Table 1). Before the physical 
examinations took place medical history was noted. The diagnostic criteria as 
well as the raters were applied in randomized order. 
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Physical examination SI Disc Facet
Drop-test positive 3
Sitting exam shows no reflex, motor or sensory signs in the legs 3
Straight leg raising (Laségue) negative between 30 and 70 degrees of passive flexion 3
Distraction (Gapping) test positive 3
Posterior shear (thigh trust) test positive 3
Pelvic torsion (Gaenslen’s) test positive 3
Patrick-Faber test positive 3
Compression test positive 3
Sacral thrust test positive 3
Cranial shear test positive 3
Bilateral internal rotation of the hip / Unilateral rotation of the hip painful at SI joint(s) 3
Yeoman’s test positive 3
Gait deviation 3
Abnormal sensory and motor examination, hyperactive or diminished reflexes 3
Digital Interspinous Pressure (DIP) test positive 3
Straight leg raising (Laségue) positive between 30 and 70 degrees of passive flexion 3
Pain in extension 3
Pain eased in flexion 3
Pain when rising from forward flexion 3
Schober test < 3-5 cm 3
Pain in extension, lateral flexion or rotation manoeuvers to the ipsilateral side 3
Replication or aggrevation of pain by unilateral pressure over the ipsilateral side 3
Local unilateral passive movements show reduced range of motion or increased stiffness 
on the side of the involved facet joints
3
Tight or facilitated muscles (psoas, hip adductors, gluteus medius muscles) 3
Weak muscles (gluteus maximus, gluteus medius) 3
Table 1: Findings from the physical examination suggestive of a SI1-8 –, disc2,3 – or facet joint2,3 pain.
We conducted this study to determine the reliability of diagnostic tests 
that point towards SI joint –, disc – or facet joint pain. The diagnostic tests 
mentioned in the literature on this subject were used.
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The first pain physician that questioned and examined the patient also took 
into account the results from spinal imaging. Each physician made a working 
diagnosis in each patient. If the working diagnoses from the three physicians 
were in agreement with each other, a general working diagnosis was made, after 
which a diagnostic test block was performed. The study flowchart is presented 
in Figure 1. The medical ethics committee from Erasmus University Medical 
Center approved the protocol. Written informed consent was obtained from all 
patients. 
Figure 1: Study flowchart.
Data were analyzed using SPSS for Windows, version 22 (International 
Business Machines (IBM) Corporation, Software Group, Route 100, Somers, 
NY, 10589, United States of America). Inter-rater reliability of nowadays most 
common used diagnostic criteria was estimated using the Cohen Kappa (k) 
index10-13. The significance level α was set to 0.05. Each variable was coded 
binary. The null hypothesis for agreement is a k of 0.
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Results
One hundred patients were included between January 2013 and April 2014. 
The progress through the fases of this inter-rater reliability study is presented 
in Figure 2. Demographic data of the patients were a median age of 55 
(interquartile range (27,25) 65.75-44.25), a mean BMI of 26.8 (standard 
deviation 5.6), 66% female gender and 100% Caucasian race. 
Figure 2: Flow diagram of the progress through the phases of the inter-rater reliability study.
Inter-rater reliability (Kappa (k) measure of agreement) and significance (p) 
between raters (raters A, B and C are pain physicians (two physicians for each 
patient), rater D an orthopedic surgeon) are presented in Tables 2a-c. 
91
INTER-RATER RELIABILITY OF DIAGNOSTIC CRITERIA FOR 
SACROILIAC JOINT-, DISC- AND FACET JOINT PAIN
Nr. A-B A-C A-D B-C B-D C-D
1 0.23 (0.01) -0.02 (0.45) 0.43 (0.03) 0.06 (0.31) 0.00 (1.00) 0.14 (0.10)
2 -0.40 (0.00) -0.28 (0.00) 0.03 (0.00) 0.10 (0.01) -0.22 (0.00) 0.86 (0.00)
3 -0.19 (0.04) -0.02 (0.55) 0.21 (0.00) 0.00 (-) -0.28 (0.00) 0.81 (0.00)
4 -0.02 (0.69) -0.01 (0.50) -0.04 (0.02) 0.00 (1.00) 0.03 (0.31) -0.14 (0.07)
5 -0.02 (0.79) -0.06 (0.08) -0.03 (0.15) -0.04 (0.49) 0.02 (0.55) -0.02 (0.85)
6 -0.09 (0.29) -0.03 (0.28) -0.11 (0.00) -0.02 (0.74) 0.07 (0.03) -0.28 (0.00)
7 -0.07 (0.51) -0.06 (0.10) -0.09 (0.00) -0.07 (0.20) 0.04 (0.21) -0.21 (0.02)
8 0.02 (0.69) -0.02 (0.36) -0.03 (0.09) 0.06 (0.26) 0.06 (0.03) 0.00 (1.00)
9 -0.16 (0.12) -0.04 (0.21) 0.01 (0.59) 0.02 (0.75) -0.08 (0.02) 0.12 (0.17)
10 -0.02 (0.81) 0.02 (0.38) -0.01 (0.59) -0.10 (0.06) -0.04 (0.18) -0.10 (0.20)
11 0.07 (0.42) 0.01 (0.79) 0.04 (0.01) 0.04 (0.43) -0.01 (0.80) 0.10 (0.15)
12 0.02 (0.81) 0.02 (0.63) 0.02 (0.50) -0.09 (0.08) 0.02 (0.56) -0.10 (0.21)
Table 2a: Inter-rater reliability (Kappa measure of agreement) and significance (p) between raters 
(raters A, B and C are pain physicians, rater D and orthopedic surgeon) of the physical examination 
suggestive of SI joint pain. 1: Drop-test positive; 2: Sitting exam shows no reflex, motor or sensory signs 
in the legs; 3: Straight leg raising (Laségue) negative between 30 and 70 degrees of passive flexion; 
4: Distraction (Gapping) test positive; 5: Posterior shear (thigh trust) test positive; 6: Pelvic torsion 
(Gaenslen’s) test positive; 7: Patrick-Faber test positive; 8: Compression test positive; 9: Sacral thrust 
test positive; 10: Cranial shear test positive; 11: Bilateral internal rotation of the hip / Unilateral 
rotation of the hip painful at SI joint(s); 12: Yeoman’s test positive.
Nr. A-B A-C A-D B-C B-D C-D
1 0.09 (0.14) -0.03 (0.09) 0.02 (0.09) 0.02 (0.31) 0.00 (1.00) 0.10 (0.01)
2 -0.09 (0.31) -0.26 (0.00) 0.04 (0.00) 0.20 (0.00) -0.12 (0.00) 0.91 (0.00)
3 0.30 (0.00) -0.03 (0.48) 0.10 (0.00) 0.22 (0.00) 0.01 (0.78) 0.42 (0.00)
Table 2b: Inter-rater reliability (Kappa measure of agreement) and significance (p) between raters 
(raters A, B and C are pain physicians, rater D an orthopedic surgeon) of the physical examination 
suggestive of disc pain. 1: Gait deviation; 2: Abnormal sensory and motor examination, hyperactive or 
diminished reflexes; 3: Digital Interspinous Pressure (DIP) test positive.
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Nr. A-B A-C A-D B-C B-D C-D
1 0.07 (0.29) -0.01 (0.50) 0.02 (0.18) 0.00 (-) 0.00 (1.00) 0.04 (0.51)
2 -0.05 (0.66) 0.04 (0.34) -0.10 (0.00) 0.00 (1.00) 0.08 (0.00) -0.30 (0.00)
3 -0.07 (0.29) -0.01 (0.69) -0.14 (0.00) 0.09 (0.08) 0.17 (0.00) -0.39 (0.00)
4 -0.09 (0.38) -0.07 (0.02) -0.09 (0.00) 0.00 (1.00) 0.00 (0.86) -0.04 (0.71)
5 0.19 (0.02) -0.04 (0.08) -0.08 (0.00) 0.07 (0.15) 0.14 (0.00) -0.18 (0.04)
6 0.07 (0.46) 0.02 (0.60) -0.06 (0.01) -0.04 (0.31) 0.07 (0.00) -0.21 (0.01)
7 0.00 (1.00) -0.12 (0.00) -0.13 (0.00) 0.06 (0.20) 0.09 (0.00) 0.00 (1.00)
8 0.16 (0.09) -0.03 (0.33) -0.19 (0.00) 0.07 (0.18) 0.21 (0.00) -0.37 (0.00)
9 0.12 (0.11) 0.02 (0.59) 0.05 (0.00) 0.07 (0.07) 0.01 (0.70) 0.10 (0.11)
10 -0.16 (0.10) -0.01 (0.79) 0.06 (0.00) -0.06 (0.21) -0.15 (0.00) 0.21 (0.00)
Table 2c: Inter-rater reliability (Kappa measure of agreement) and significance (p) between raters 
(raters A, B and C are pain physicians, rater D an orthopedic surgeon) of the physical examination 
suggestive of facet joint pain. 1: Straight leg raising (Laségue) positive between 30 and 70 degrees 
of passive flexion; 2: Pain in extension; 3: Pain eased in flexion; 4: Pain when rising from forward 
flexion; 5: Schober test < 3-5 cm; 6: Pain in extension, lateral flexion or rotation manoeuvers to the 
ipsilateral side; 7: Replication or aggrevation of pain by unilateral pressure over the ipsilateral side; 8: 
Local unilateral passive movements show reduced range of motion or increased stiffness on the side of the 
involved facet joints; 9: Tight or facilitated muscles (psoas, hip adductors, gluteus medius muscles); 10: 
Weak muscles (gluteus maximus, gluteus medius).
Strengths of agreement are presented in order of agreement for values k > 0,20 
in Table 3. 
k Nr Raters
0.91 Abnormal sensory and motor examination, hyperactive or diminished reflexes C-D
0.86 Sitting exam shows no reflex, motor or sensory signs in the legs C-D
0.81 Straight leg raising (Laségue) negative between 30 and 70 degress of passive flexion C-D
0.43 Drop test positive A-D
0.42 Digital interspinous pressure test positive C-D
0.30 Digital interspinous pressure test positive A-B
0.23 Drop test positive A-B
0.22 Digital interspinous pressure test positive B-C
0.21 Weak muscles (gluteus maximus, gluteus medius) C-D
0.21 Local unilateral passive movements show reduced range of motion or increased stiffness on 
the side of the involved facet joints
B-D
0.21 Straight leg raising (Laségue) negative between 30 and 70 degrees of passive flexion A-D
Table 3: Strength of agreement beyond chance, indicated with k values above 0.20 (< 0: poor; 0-0.20: 
slight; 0.21-0.40: fair; 0.41-0.60: moderate; 0.61-0.80: substantial; 0.81-1.00: almost perfect). The k 
values used are from Landis and Koch12 and are in order in agreement.
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None of the parameters from the physical investigation had k values of more 
than 0,21 (fair) in all pairs of raters. Between two raters (C and D), there was 
an almost perfect agreement on three parameters, more specifically “Abnormal 
sensory and motor examination, hyperactive or diminished reflexes”, “Sitting 
exam shows no reflex, motor or sensory signs in the legs” and “Straight leg 
raising (Laségue) negative between 30 and 70 degrees of flexion”. The “Drop 
test positive” parameters had moderate strength of agreement between raters 
A and D and fair strength between raters A and B. The “Digital interspinous 
pressure test positive” had moderate strength of agreement between raters C 
and D and fair strength of agreement between raters A and B as well as raters 
B and C. Three other parameters (Table 3) had a fair strength of agreement 
between two raters, all other parameters had a slight or poor strength of 
agreement. 
Inter-rater reliability (including confidence intervals and significance) of 
pooled items for SI joint -, disc – and facet joint pain are represented in Tables 
4a-c. Kappa values for the pooled parameters of the physical examination 
suggestive of SI joint pain stayed below 0.2 between all raters. The same applies 
for the pooled parameters of the physical examination suggestive of facet joint 
– or disc pain.
During the study we recorded no (serious) adverse events.
Rater A
k; p; (95% CI k)
Rater B
k; p; (95% CI k)
Rater D
k; p; (95% CI k)
Rater A 0.124; 0.006
(0.034;0.214)
Rater B 0.169; < 0.001
(0.085;0.252)
0.136; 0.001
(0.052;0.219)
Rater C 0.130; 0.004
(0.035;0.225)
0.166; < 0.001
(0.082;0.251)
0.036; 0.44
(0;0.129)
Table 4a: Inter-rater reliability (Kappa measure of agreement) (raters A, B and C are pain physicians, 
rater D an orthopedic surgeon), significance (p) and 95% confidence intervals (CI) of the pooled items of 
the physical examination parameters suggestive for SI joint pain. 
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Rater A
k; p; (95% CI k)
Rater B
k; p; (95% CI k)
Rater D
k; p; (95% CI k)
Rater A 0.194; 0.000
(0.075;0.313)
Rater B N/A 0.191; 0.001
(0.009;0.373)
Rater C 0.205; 0.003
(0.070;0.341)
0.093; 0.145
(0;0.232)
0.129; 0.001
(0.051;0.207)
Table 4b: Inter-rater reliability (Kappa measure of agreement) (raters A, B and C are pain physicians, 
rater D an orthopedic surgeon), significance (p) and 95% confidence intervals (CI) of the pooled items of 
the physical examination parameters suggestive for disc pain (N/A: concordance is smaller than mean-
chance).
Rater A
k; p; (95% CI k)
Rater B
k; p; (95% CI k)
Rater D
k; p; (95% CI k)
Rater A 0.313; 0.000
(0.255;0.372)
Rater B 0.258; 0.000
(0.173;0.343)
0.307; 0.000
(0.241;0.373)
Rater C 0.357; 0.000
(0.275;0.440)
0.232; 0.000
(0.111; 0.354)
0.276; 0.000
(0.205;0.346)
Table 4c: Inter-rater reliability (Kappa measure of agreement) (raters A, B and C are pain physicians, 
rater D an orthopedic surgeon), significance (p) and 95% confidence intervals (CI) of the pooled items of 
the physical examination parameters suggestive for facet joint pain.
Conclusion and discussion
We conducted this study to determine the reliability of diagnostic tests 
that point towards SI joint –, disc – or facet joint pain, using diagnostic 
tests mentioned in the literature on these subjects. The null hypothesis for 
agreement is a k of 0. None of the diagnostic tests used in this study had k 
values of more than 0.21 (fair) in all pairs of raters. Also, the k values in all 
pairs of raters of the pooled items of the physical examination parameters 
suggestive for SI joint -, disc – or facet joint pain stayed below 0.2. The poor 
reliability of the diagnostic parameters seriously limits their predictive validity, 
and as such their use in patients with low back pain for more than 3 months.
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Kappa is an adequate measure for inter-rater agreement. Kappa has the 
advantage that it is corrected for agreement with statistical chance. The main 
disadvantage is that it is not free of dependence on disease prevalence or the 
number of rating categories. As a consequence it can be difficult to interpret 
the meaning of any absolute value, but is still useful if disease prevalence and 
number of categories are presented12.
In correlating the clinical examination characteristics in 81 individuals (a total 
of 104 injection procedures were performed), both centralization of pain and 
pain when rising from sitting were significantly associated with a positive 
discogram2, while not having pain when rising from sitting was strongly 
correlated with a positive facet joint injection. The presence of midline lumbar 
pain tends to exclude the SI joint as a potential pain generator. When there 
were three or more positive SI joint pain provocation tests, the presence of a 
SI joint source of pain is 28 times more likely. The physical examinations were 
performed by visiting physical therapists and the injections were performed if 
requested by the referring physician or deemed adequate by a radiologist, while 
in our study all parts of the trial were performed by the same physicians and on 
the basis of a general working diagnosis. 
In a systematic review of tests to identify the source of low back pain, no 
available clinical test was found which could be used to increase or decrease 
the likelihoofd of the disc as the source of low back pain3. Also, the currently 
available tests have limited or no diagnostic validity regarding investigating the 
facet joint as the source of low back pain; our study is in accordance with this 
review in that we also found no useful diagnostic tests. 
A combination of SI joint provocation tests appears to be useful to increase 
the likelihood of the SI joint as the source of pain. However, in a small study 
performed by physical therapists examining the intertester reliability of 
tests for SI joint dysfunction, the reliability was poor for all tests, except the 
iliac gapping and compression tests14. In our study, we found that no single 
parameter of the physical examination nor the pooling of these tests was useful 
to increase the likelihood of the SI joint as the source of pain; the same applies 
to the parameters of the physical examination suggestive for disc – or facet 
joint pain.
Only a small amount of investigation has been performed into the diagnostic 
accuracy of clinical tests. In our study we investigated the diagnostic accuracy 
of these tests in 100 patients referred to a pain center because of chronic low 
back pain and found a poor reliability of all diagnostic parameters.
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Abstract
The aim of this observational study is to investigate the accuracy of lumbar 
X-ray imaging and MRIs as diagnostic tools of low back pain (LBP) subtypes. 
Included were patients with medical history and physical examination 
suggestive of a chronic LBP subtype, followed by a diagnostic test block. One 
hundred patients were included. No general working diagnosis could be made 
in 17 patients. Facet joint pain was a general working diagnosis in 40 patients, 
disc pain in 8 patients and SI joint pain in 35 patients. The PPV of X-ray was 
82.6% for facet joint pain, 66.7% for disc pain and 60% for SI joint pain; the 
NPV of X-ray was 50% for facet joint pain, 66.7% for disc pain and 7.7% for 
SI joint pain. The PPV of MRI was 81.8% for facet joint pain, 50% for disc 
pain and 0% for SI joint pain; the NPV of MRI was 55.6% for facet joint 
pain, 0% for disc pain and 13% for SI joint pain. In conclusion, the predictive 
validity of lumbar X-ray imaging and MRIs to distinguish between LBP 
subtypes in patients with chronic LBP is questionable.
Introduction
Low back pain (LBP) continues to be a very common problem globally and 
will increase in prevalence over the next years1, 2. Low back pain causes more 
disability than any other condition and ranks highest in terms of disability 
and sixth in terms of overall burden2, 3. Besides its negative impact on physical 
functioning and the quality of life, treatment of LBP is costly; 2% of all 
physician office visits are for low back pain complaints4. 
Ageing affects the spinal elements and causes a certain degree of degeneration, 
resulting in changes such as a reduction of disc height and altered load 
transmission across the vertebral endplates and paired facet joints (the three-
joint spinal complex)5. Identification of the pain-producing structure is not 
easy in degenerative spinal disease. The intervertebral disc, facet joint and 
sacro-iliac (SI) joint can act as a major cause of chronic low back pain and 
referred pain. The prevalence of internal disc disruption, facet joint pain and SI 
joint pain was 39-42%6, 7, 15-31%7, 8 and 10-38%7-9, 11, respectively; the younger 
the patient, the more likely LBP is discogenic in origin7. 
We recently have investigated the effect on pain reduction and global perceived 
effect (GPE) of a percutaneous radiofrequency (RF) heat lesion compared to 
a sham procedure, applied to the ramus communicans 12, the medial branch 
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of the primary dorsal ramus13 and the dorsal ramus of L5 and lateral branches 
of the S1, S2, S3 and S4 nerve roots14. Based on the results of the sham-
controlled trials the H0 hypothesis of no difference in pain reduction or in 
GPE between the treatment and the sham groups could not be rejected.
We asked ourselves what is known about the diagnostic accuracy of the 
physical examination, X-ray imaging and MRIs in diagnosing chronic low 
back pain subtypes. The inter-rater reliability of diagnostic tests that point 
towards SI joint –, disc – or facet joint pain was investigated in a subsequent 
study15. 
Judging from spinal imaging tests whether the cause of chronic LBP is 
due to intervertebral disc degeneration, facet arthritis, or SI arthritis can be 
challenging16. When determining the association between deviations on spinal 
imaging and LBP, the research data yield conflicting results. Patients with disc 
herniations may have no symptoms17-20, while patients with severe symptoms 
demonstrated no evidence on imaging of nerve root compression at all21-23.  
The severity of symptoms is not well correlated with the size of the herniation 
24-27 and features on imaging may have little prognostic value towards outcome 
28-32.
Routine imaging can be associated with radiation exposure, increased expenses 
and possibly unnecessary procedures33. Patient expectations and increasing 
satisfaction may play a role. Clinical practice guidelines for the diagnosis and 
treatment of LBP have been developed in the past34. Appropriateness criteria 
for LBP were issued by the American College of Radiology (1996, last revision 
201135.
The aim of this study is to investigate the accuracy of lumbar X-ray images 
and MRIs as diagnostic tools of LBP subtypes (SI joint, disc and facet joint). 
Whether or not abnormalities were visible on the spinal imaging tests was 
judged by a radiologist and a pain physician.
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Materials and Methods
We conducted an observational study alongside the inter-rater reliability 
trial (International Standard Randomised Controlled Trial Number Register 
(Current Controlled Trials) 43417727) to investigate the accuracy of lumbar 
X-ray images and MRIs as diagnostic tools of LBP subtypes. Patients 
who were referred because of their chronic LBP received three separate 
consultations (two from experienced pain physicians and one from an 
experienced orthopaedic surgeon) within a period of two weeks to decrease the 
chance for confounding and jointly determine the cause of the pain problem. 
Findings from the physical examination suggestive of a SI joint, disc or facet 
joint pain problem are presented in Table 136-40. 
Physical examination SI Disc Facet
Drop-test positive 3
Sitting exam shows no reflex, motor or sensory signs in the legs 3
Straight leg raising (Laségue) negative between 30 and 70 degrees of passive flexion 3
Distraction (Gapping) test positive 3
Posterior shear (thigh trust) test positive 3
Pelvic torsion (Gaenslen’s) test positive 3
Patrick-Faber test positive 3
Compression test positive 3
Sacral thrust test positive 3
Cranial shear test positive 3
Bilateral internal rotation of the hip / Unilateral rotation of the hip painful at SI joint(s) 3
Yeoman’s test positive 3
Gait deviation 3
Abnormal sensory and motor examination, hyperactive or diminished reflexes 3
Digital Interspinous Pressure (DIP) test positive 3
Straight leg raising (Laségue) positive between 30 and 70 degrees of passive flexion 3
Pain in extension 3
Pain eased in flexion 3
Pain when rising from forward flexion 3
Schober test < 3-5 cm 3
Pain in extension, lateral flexion or rotation manoeuvers to the ipsilateral side 3
Replication or aggravation of pain by unilateral or bilateral pressure over the facet joints or 
transverse process
3
Local unilateral or bilateral passive movements show reduced range of motion or increased 
stiffness on the side of the involved facet joints
3
Tight or facilitated muscles (psoas, hip adductors, gluteus medius muscles) 3
Weak muscles (gluteus maximus, gluteus medius) 3
Table 1: Findings from the physical examination suggestive of a SI joint, disc or facet joint pain 
problem [36-40].
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A training session was held before the study to ensure as much consistency as 
possible of methods and standardization of test procedures, during which every 
item from the list with diagnostic criteria were judged on their presence or 
absence. Medical history was noted, along with the results from spinal imaging. 
Patients suspected of a lumbar spine related pain disorder who met the 
inclusion - (age ≥ 18 years, chronic (> 3 months) LBP) and exclusion criteria 
(presence of red flags41, progressive neurological deficits, major psychiatric 
disorder (according to psychiatrists opinion), pain in other parts of the body 
that is more severe, pregnancy, active infection, communication (language) 
difficulties (according to physicians opinion)) were eligible for inclusion. If 
the working diagnoses from the three physicians were in agreement with each 
other, a general working diagnosis was made, after which a diagnostic test 
block (gold standard) was performed: 
1) Diagnostic SI joint test block
The injection was performed under fluoroscopy with a 10 cm Sluijter-Mehta 
Kit (SMK) needle (Cotop® via Neurotherm®, Wilmington, Massachusetts, 
United States). The patient lies in the prone position on the operating table 
with a pillow under the pelvis. From the anteroposterior (AP) view, the 
c-arm is rotated contralaterally until the medial cortical line of the posterior 
articulation is in focus. Local anesthesia with 1 mL lidocaine 2% was given for 
skin infiltration. Needle insertion is 1-2 cm cranially from the lower border of 
the SI joint at the level of the zone of maximal radiographic translucency.
Introduction of the needle into the SI joint is characterized by a change in 
resistance. On a lateral view, the needle tip should appear anterior to the  
dorsal border of the sacrum. The SI joint was injected with a total of 3 mL 
lidocaine 2%.
2) Diagnostic test block at the ramus communicans
The injection was performed under fluoroscopy with 15 cm Sluijter-Mehta 
Kit (SMK) needles (Cotop® via Neurotherm®, Wilmington, Massachusetts, 
United States). The patient lies prone on the operating table with a pillow 
under the abdomen to flatten the lumbar lordosis. From the AP view, the 
c-arm is rotated obliquely to the ipsilateral side so that facet joints are 
projected away and the vertebral column is clearly visible. From the sagittal 
plane, the c-arm is rotated to let the transverse process change its location 
relative to the vertebral body and, as a result, the axis of the transverse process 
lies slightly above the middle of the vertebral body. The injection point is 
marked just caudally to the transverse process and somewhat medially to the 
lateral border of the vertebral body. Local anesthesia with 1 mL lidocaine 2% 
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was given for skin infiltration. The needle is advanced until contact is made 
with the vertebral body. On the lateral view, the tip of the needle should be 
somewhat ventral to the posterior side of the lateral body. After sensory  
(50 Hz) and motor (2 Hz) stimulation as an adjunct to confirm correct needle 
placement, the ramus communicans was surrounded with a total of 0.5 mL 
lidocaine 2%.
3) Diagnostic test block at the medial branch of the primary dorsal ramus
The injection was performed under fluoroscopy with three 10 cm Sluijter-
Mehta Kit (SMK) needles (Cotop® via Neurotherm®, Wilmington, 
Massachusetts, United States of America) at the facet joint that was presumed 
to be the source of the pain and then at the two adjacent levels (in the case 
of the L5/S1 facet joint level, the adjacent L4/L5 facet joint level was also 
treated). The patient lay prone on the operating table with a pillow under 
the abdomen in order to flatten the lumbar lordosis. From the AP view, the 
c-arm was rotated obliquely to the ipsilateral side so that the junction between 
the superior articular process and the transverse process was more easily 
accessible. Local anesthesia with 1 mL lidocaine 2% per level was given for 
skin infiltration. Contact was made with the transverse process as close as 
possible to the superior articular process. After contacting bone, the needle 
was advanced slightly in a cranial direction so that its tip slides over the 
transverse process. In the lateral view the electrode tip lay at the base of the 
superior articular process at the lower aspect of the intervertebral foramen, 
approximately 1 mm dorsal to its posterior border. After sensory (50 Hz) - and 
motor (2 Hz) stimulation (contraction of the ipsilateral multifidus muscle and 
excluding a too close proximity to the segmental nerve), each medial branch 
was surrounded with a total of 0.5 mL lidocaine 2%.
The diagnostic test injection was evaluated using the Numerical Rating Scale 
(NRS, 0-10 point scale)42-47 for pain. When employing the NRS for pain 
patients are asked to rate their pain on a scale from 0 to 10, where 0 represents 
“no pain” and 10 represents “the worst pain possible,” using whole numbers (11 
integers including zero); if the decrease in NRS was equal to or greater than 2, 
the test was called positive42.
Numbers of spinal imaging tests were noted for the entire sample and LBP 
subtypes. The presence of abnormalities on each lumbar spinal imaging test was 
judged by a radiologist as well as a pain physician; presence itself was assumed 
when at least one physician described it. The study flowchart is presented in 
Figure 1. 
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Figure 1. Study flowchart.
The medical ethics committee from the Erasmus MC University Medical 
Center approved the protocol (reference number MEC-2011-246). Written 
informed consent was obtained from all patients. 
The predictive validity of X-ray images and MRIs in patients with a diagnosis 
of a LBP subtype (SI joint, disc and facet joint) was determined by assessing 
the sensitivity, specificity, positive – and negative predictive value. Data were 
analysed using SPSS for Mac, version 22 (International Business Machines 
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(IBM) Corporation, Software Group, Route 100, Somers, NY, 10589, United 
States of America).
Results
One hundred patients were included between January 2013 and April 2014. 
Demographic data of the patients were a median age of 55 (interquartile range 
(75,25) 65.75-44.25), a mean BMI of 26.8 (standard deviation 5.6), 66% 
female gender and 100% Caucasian race. The progress through the phases of 
the inter-rater reliability study is presented in Figure 2. 
Figure 2: progress through the phases of the inter-rater reliability trial.
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Demographic data of the patients were a median age of 55 (interquartile 
range (27,25) 65.75-44.25), a mean BMI of 26.8 (standard deviation 5.6), 
66% female gender and 100% Caucasian race. Numbers of lumbar spinal 
imaging tests for the entire sample as well as for the LBP subtypes (before the 
diagnostic test block) are presented in Table 2. 
Group (before test 
block)
Nr X-ray made CT made MRI made
Total 100 90 (90%) 2 (2%) 61 (61%)
Facet joint 40 37 (92.5%) 2 (2%) 20 (50%)
Disc 8 6 (75%) 0 (0%) 6 (75%)
Sacroiliac joint 35 31 (88.6%) 0 (0%) 23 (65.7%)
Table 2: Total number of spinal imaging techniques, as well as for each subtype (differential diagnosis).
Lumbar X-ray imaging was used in 90% of the patients in the sample, MRI 
in 61%. No general working diagnosis could be made in 17 patients; these 
patients were excluded from the study. 
Deviations present on lumbar X-ray imaging for each LBP subtype, and 
including the outcome of the diagnostic test block are presented in Table 3. 
Group Nr X-ray made 
(%)
Facet joint 
pathology 
present (%)
Disc pathology 
present (%)
Sacroiliac joint 
pathology 
present (%)
Facet joint (test block positive) 29 26 (89.6) 19 (73.1) 23 (88.5) 1 (3.8)
Facet joint (test block negative) 11 11 (100) 4 (36.4) 9 (81.2) 0 (0)
Disc (test block positive) 5 3 (60) 1 (33.3) 2 (66.7) 0 (0)
Disc (test block negative) 3 3 (100) 1 (33.3) 1 (33.3) 0 (0)
Sacroiliac joint (test block positive) 31 27 (87.1) 16 (59.2)1 18 (66.7)1 3 (11.1)
Sacroiliac joint (test block negative) 4 4 (100) 4 (100) 4 (100) 2 (50)
Table 3: Pathology present on X-ray for each subtype of low back pain, depending on the outcome of the 
test block (1: 1 missing data entry).
When the facet joitnt was considered to be the primary source of pain and the 
diagnostic test block was positive (decrease in numerical rating scale for pain of 
2 or more on a 0-10 point scale42), facet joint abnormalities were seen on X-ray 
imaging in 73.1%, disc abnormalities (in these same patients) in 88.5%. 
Deviations present on lumbar MRI for each LBP subtype, and including the 
outcome of the diagnostic test block are presented in Table 4. 
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Group Nr MRI 
made
Facet joint 
pathology 
present (%)
Disc pathology 
present (%)
Sacroiliac joint 
pathology 
present (%)
Facet joint (test 
block positive)
29 13 (44.8) 9 (69.2) 13 (100) N/A
Facet joint (test 
block negative)
11 7 (63.4) 2 (28.6) 6 (85.6) N/A
Disc (test block 
positive)
5 3 (60) 2 (66.7) 3 (100) N/A
Disc (test block 
negative)
3 3 (100) 0 (0) 3 (100) N/A
Sacroiliac joint 
(test block 
positive)
31 20 (64.5) 9 (45) 20 (100) 0 (0)1
Sacroiliac joint 
(test block 
negative)
4 3 (75) 1 (33.3) 3 (100) 0 (0)2
Table 4: Pathology present on MRI for each subtype of low back pain, depending on the outcome of the 
test block (1: 17 missing data entries (MRI of lumbar spine); 2: 3 missing data entries (MRI of lumbar 
spine).
Disc abnormalities were present in almost 100% of cases, irrespective of the 
results from the diagnostic test block and the general working diagnosis. 
The sensitivity, specificity, positive – and negative predictive value of X-ray 
imaging in the population with chronic LBP and in each LBP subtype is 
presented in Table 5, these of MRI in Table 6. 
X-ray
Sensitivity (%) PPV
(%)
Specificity (%) NPV
(%)
Facet joint 73.1 82.6 63.6 50
Disc 66.7 66.7 66.7 66.7
Sacro-iliac joint 11.1 60 50 7.69
Table 5: Sensitivity, specificity and predictive validity of lumbar spinal X-ray (PPV = Positive 
Predictive Value; NPV = Negative Predictive Value).
MRI
Sensitivity (%) PPV
(%)
Specificity (%) NPV
(%)
Facet joint 69.2 81.8 71.4 55.6
Disc 100 50 0 0
Sacro-iliac joint 0 0 100 13
Table 6: Sensitivity, specificity and predictive validity of lumbar spinal MRI scan (PPV = Positive 
Predictive Value; NPV = Negative Predictive Value).
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The positive predictive value of lumbar X-ray imaging for facet joint pain was 
82.6%, the negative predictive value 50%. The positive predictive value of MRI 
for disc pain was 50%, the negative predictive value 0%. During the study we 
recorded no adverse events. 
Discussion
This trial investigated the sensitivity, specificity and predictive value of X-ray 
and MRI in respect to the effectiveness of the diagnostic test block in patients 
in whom medical history and physical examination point towards a LBP 
subtype (SI joint, disc or facet joint). The results of this study show that the 
predictive validity of the lumbar spinal images in distinguishing between LBP 
subtypes is questionable.
Anatomic changes normally occur as a result from ageing and have the 
potential of producing mechanical and clinical symptoms. Loss of disc height 
alters the transmission of loads across structures like the facet joints, increasing 
further loading on adjacent structures. Establishing an accurate diagnosis 
of the specific source of low back pain will help in directing (or avoiding) 
treatment towards the source of the symptoms. 
In the population without low back pain, the percentage of people with 
disc abnormalities varied between 31 and 64%24, 25, while in this sample 
the prevalence of disc abnormalities in the patients with LBP was 100%, 
irrespective of the general working diagnosis. Furthermore, facet abnormalities 
were seen in 8% of people without LBP24, but increased to 69.2% in the 
sample of patients with LBP when a working diagnosis of facet joint pain 
was established. From the MRI studies in people with and without low back 
pain we know that the high prevalence of disc abnormalities, combined 
with the high prevalence of back pain, bulging discs and protrusions of the 
disc may frequently be coincidental 13-16, 20-23 ; therefore, in chronic LBP, disc 
abnormalities cannot be used to distinguish one LBP type from the other. 
A limitation of this study is that during the first consultation the pain 
physician took into account the results from lumbar spinal imaging, i.e. to 
exclude red flags. Perhaps this moment biased our results in moving more 
specifically towards a LBP subtype.
There were relatively few individuals under the age of 40 present in the study. 
This limits the interpretation and generalizability of the study findings.
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Conclusions
We conducted this study to investigate the accuracy of lumbar X-ray imaging 
and MRIs as diagnostic tools of LBP subtypes (SI joint, disc and facet joint). 
Based on the results from this study, the predictive validity of lumbar X-ray 
imaging and MRIs to distinguish between LBP subtypes in patients with 
chronic LBP is questionable. 
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Introduction
Vertebral fractures often are very painful and lead to reduced quality of 
life and disability1. Common causes of vertebral fractures are osteoporosis 
(postmenopausal, secondary), trauma, primary tumors of the spine and 
metastasis. The worldwide burden of osteoporotic fractures in the year 2000 
was estimated to be 9 million, among them 1.4 million clinical vertebral 
fractures2; about a third come to medical attention3,4. The incidence of 
osteoporotic clinical vertebral fractures in The Netherlands was estimated to 
be 0.7% in women and 0.2% in men aged 55 years or older5. Traumatic spinal 
fractures occur in 11.8 to 16.4 per 100000 population (0.012-0.016%)6,7; the 
most common causes were a high-energy fall (39%, evenly distributed over the 
whole spine) and traffic accidents (26.5%, more fractures at the cervical and 
thoracic spine)8. The spine is also the most frequent site of bone metastasis. 
Spinal involvement may occur in up to 40% of patients with cancer and 
approximately 70% of patients with cancer have evidence of metastatic disease 
at the time of their deaths9. As many as 75% of vertebral metastases occur 
in patients with carcinoma of the breast, kidney, lung, prostate, thyroid and 
multiple myeloma10,11. Vertebral compression fractures occur in 55% to 70% of 
patients with multiple myeloma and is the initial clinical sign in 34% to 64% of 
these patients4. 
Usual treatment for vertebral osteoporotic compression fractures consists out 
of analgesics, bed rest, casting and physical support. Other modalities were 
introduced depending on the clinical presentation and spinal level, aiming 
at the vertebra itself (e.g. radiotherapy, surgical approaches and/or cement 
augmentation). Cement augmentation evolved into a percutaneous technique, 
injecting cement into the fractured vertebral body. Balloon kyphoplasty (BKP) 
seems to be a safe, minimally invasive procedure for the treatment of painful 
vertebral fractures, which is intended to reduce pain and disability and correct 
vertebral body deformity using balloons12-18. Studies have demonstrated that 
cement augmentation procedures provide better clinical outcome compared to 
non-surgical management1,3,12,19. When comparing BKP with vertebroplasty 
(VP), the first proved to have better results, which are maintained over long-
term follow-up20-23, with less side effects such as cement leakage24. In patients 
with cancer, BKP proved to be an effective and safe treatment that rapidly 
reduces pain and improves function25-31; a biopsy can routinely be performed32. 
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Comparing to surgery, percutaneous cement treatment predicts significantly 
reduced costs as well as length of stay33,34. The use of BKP or VP in the 
management of vertebral compression fractures in patients with cancer may be 
a cost-effective strategy35. 
In 2009, two articles appeared in the New England Journal of Medicine, 
reporting that improvements made in pain (and pain related disability) by 
VP in patients with painful vertebral osteoporotic compression fractures 
were similar in the treatment group and the sham group36,37. The results of 
these trials seem to be in disagreement with the accumulated literature on 
this subject38. In one study36, MRIs and/or bone scans were not required if 
the fracture was known and under one year of age. The targeted level was 
250 patients, but only 131 subjects were enrolled. Eight patients (12%) in 
the vertebroplasty group crossed over to the sham group, while 43% (27) of 
patients from the sham group crossed over to the vertebroplasty group. In 
the other study37, out of 219 eligible patients, only 78 (36%) were enrolled. 
While being a multicenter trial, more than 67% of the patients came from a 
single site. The mean volume injected into the vertebrae was (only) 2.8 mL. 
A meta-analysis of the individual patient data in the two randomised placebo 
controlled trials (RCTs) failed to show an advantage of VP over placebo39. 
More discussion regarding the differences between placebo efficacy and specific 
efficacy was provided in another article by Miller, Kallmes and Buchbinder40. 
Complications associated with BKP are attributed to the technique itself (e.g. 
cement leakage, infection) and/or cadiopulmonary events (e.g. cement, fat, 
bone marrow or air embolisation). These major complications are rarely seen, 
but may warrant a high level of suspicion and immediate action, e.g. early 
surgical intervention and/or pharmacological treatment41-47. 
This case series study reports on pain reduction after BKP in patients with 
painful vertebral compression fractures due to osteoporosis, trauma or cancer, 
who were referred to the pain center of a general hospital. All BKP procedures 
were performed by experienced interventional pain physicians.
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Methods
Study design
We performed a case series study on the effectiveness of BKP for painful 
vertebral compression fractures in 60 patients with acute axial lumbar and/or 
thoracic spinal pain. 
Participants
Patients were referred to the pain center of a general hospital with complaints 
of acute axial pain on lumbar and/or thoracic level. These patients were 
managed according to the flowchart presented in Figure 1. When a painful 
vertebral compression fracture was suspected (Table 1) and patients satisfied 
to the indications and contra-indications (Table 2), they were eligible for BKP. 
Each patient received a brochure explaining the complete procedure. After 
obtaining written informed consent for the procedure patients were scheduled 
for BKP.
Figure 1: Procedure flowchart.
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Medical history
1. Acute (deep) spinal pain episode
2. Trauma
3. Most comfortable when motionless
4. Osteoporosis
5. Cancer
6. Previous vertebral compression fracture(s)
7. Persistent pain after acute pain episode subsided
8. Abdominal symptoms (early satiety, abdominal bloating)
9. Anorexia and subsequent weight loss
10. Lower rib syndrome
11. Inactive, sedentary lifestyle
12. Fear of falling
13. Sleep pattern disturbed (due to pain and inactivity)
14. Depression
Physical examination
1. Tenderness to deep palpation and percussion over the affected vertebra
2. Para spinal muscle spasm
3. Short thoracic spine, kyphosis
4. Decreased pulmonary function (restrictive lung disease and reduced vital capacity)
Additional tests
1. Lateral X-ray of spine
2. MRI
Table 1: Medical history, physical examination and additional tests used in establishing the diagnosis of 
painful vertebral compression fractures.
Indications
1. Medical history, physical examination and additional tests suggestive of painful vertebral compression fracture on 
lumbar and/or thoracic level
2. Vertebral edema present on MRI
3. Numerical Rating tScale equal to or higher than 4/10
4. Preoperative anesthetic screening warrents the use of continuous IV sedation and analgesia
Contra-indications
1. Active infection
2. Progressive neurological deficits
3. Major psychiatric disorder (according to psychiatrists opinion)
4. Anticoagulation cannot be stopped
5. Allergies to any medication or cement
6. Pregnancy
7. Contra-indication for MRI
Table 2: indications and contra-indications for balloon kyphoplasty.
Intervention
Monitoring of vital parameters took place according to the American Society 
of Anesthesiologists House of Delegates Standards for Basic Anesthetic 
Monitoring (ASA)48. Antibiotic prophylaxis was provided with Cephazolin 2 
g. Continuous Oxygen 15 L/min through a non-rebreather mask and bag was 
applied and patients were placed in the prone position using pillows under the 
chest and pelvic area. Continuous sedation with intravenous (IV) propofol 
Target Controlled Infusion (TCI) 0.5 µg/mL and continuous analgesia with 
IV remifentanyl 0.05 µg/kg/min was used.  
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Doses were titrated to a Ramsay score of 4 out of 649. Continuous IV sedation 
and analgesia was provided to the patient by a nurse anaesthetist with 
subsequent training in sedation.
Skin – and periosteal infiltration was performed at each side with Lidocaine 
2%. Under fluoroscopic guidance, a bilateral trans- or extrapedicular 
approach was used with introducer tools and inflatable balloon-like devices, 
polymethylmethacrylate (PMMA) bone cement and delivery devices (Kyphon 
inc. / Medtronic Spine LLC, 1221 Crossman Ave, Sunnyvale, CA 94089, 
United States of America). During each procedure, a biopsy was taken and 
a combination of Paracetamol 1 g IV, Dynastat 40 mg IV and Morphine 0.1 
mg/kg IV was given for immediate postoperative pain management. Wound 
edges were infiltrated with Ropivacaine 0.2%.
Measurements
The main outcome parameter was pain reduction (Numerical Rating Scale 
(NRS) for pain)50-54. The 0–10 verbal NRS for pain is a tool that enjoys 
widespread clinical use due to its ease of administration. While using the 
NRS for pain, patients are asked to rate their pain on a scale from 0 to 10, 
where 0 represents “no pain” and 10 represents “the worst pain possible,” using 
whole numbers (11 integers including zero). Often the value of “4” is used to 
confirm clinical nursing judgment as to the need for further intervention or 
documentation that the patient’s goals for analgesia have been achieved. The 
NRS for pain was measured preoperatively (T0) and during follow-up.
Follow-up
Time periods for follow-up were on the first postoperative day (T1), at 3 
months (T2) and at 12 months (T3).
Statistical considerations
Descriptive statistics were used to determine the frequencies of the 
demographic and the outcome parameters. Using the Kolmogorov-Smirnov 
test, the distributions of these parameters appeared to be skewed. Therefore, 
central tendency and dispersion of the distributions are reported as median and 
interquartile range (IQR). 
Differences in pain level between baseline (preoperative, T0) and postoperative 
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(T1, T2 and T3) time periods were analyzed using the related-samples 
Friedman’s Two-Way Analysis of Variance by Ranks. Post-hoc pairwise 
comparisons were performed with the Related Samples Wilcoxon Signed 
Rank Test, using a Bonferoni correction to counteract the problem of multiple 
comparisons.
The independent-samples Mann-Whitney U test was used to study the 
hypothesis that the distribution of the NRS for pain scores (T0-T1) is the 
same in the patients with osteoporosis and those with cancer.
Data were analyzed using SPSS for Mac, version 22 (International Business 
Machines (IBM) Corporation, Software Group, Route 100, Somers, NY, 
10589, United States of America).
Results
Sixty patients were treated with BKP for painful vertebral compression 
fractures and had follow-up for 1 year. The procedure is presented in Figure 
2. Demographic data are presented in Table 3. Vertebral fracture levels are 
presented in Figure 3. Most fractures occurred at the Th12-L1 region. The pain 
intensity levels appeared to be statistically significant different between the 
pain level at baseline (T0) and the three moments of measurement after the 
procedure, p<.001 (Figure 4). No statistically significant difference was found 
between the three moments of measurement after the procedure. Results of the 
pairwise comparisons are presented in table 4. 
Figure 2: Progress through the phases of the procedure.
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Group N (F, %) Age BMI
Median IQR (Q3-Q1) Median IQR (Q3-Q1)
Osteoporosis 40 (28, 70) 77 16 26 7.3
Trauma 3 (2, 66.7) 59 N/A 27.9 N/A
Cancer 17 (10, 58.8) 71 11 22.8 10.3
Table 3: demographic data of the patients (100% Caucasian) in the study (IQR: Interquartile range; N: 
number of patients; F: Female).
Figure 3: Vertebral fracture levels (Y-axis) and number of patients (X-axis) with vertebral compression 
fractures due to osteoporosis, trauma and cancer.
T0 T1 T2
T0
T1 < .001
T2 < .001 .41
T3 < .001 .12 .43
Table 4: results (p-value) of the pairwise comparisons between the moments of measurement, using 
a Bonferroni correction (α = 0.08) (T0: before the BKP procedure; T1: first postoperative day; T2: 3 
months after treatment; T3: 12 months after treatment).
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Figure 4: Boxplot of the pain intensity before vertebral augmentation (NRS before), first postoperative 
day (NRS 1 day), at 3 months (NRS 3 months) and at 12 months (NRS 12 months) in patients with 
painful vertebral compression fractures due to osteoporosis, trauma or cancer.
In 40 patients, a painful vertebral compression fracture was present due to 
osteoporosis, in three patients due to trauma and in 17 patients due to cancer 
(five patients with multiple myeloma, six with metastatic lung cancer, two 
with metastatic breast cancer, two with metastatic prostate cancer, one with 
metastatic ovary cancer and one with metastatic cervix cancer). No statistically 
significant difference in NRS for pain was found between the patients with 
osteoporosis and those with cancer between T0 and T1 (p=.48).
In the patients with cancer, one patient died after one day, another ten within 
one month and another two within three months. In the patients with 
osteoporosis, one patient died within one month and another one within three 
months. In the patients with traumatic vertebral compression fracture, no one 
died within the follow-up period of 1 year. No major complications occurred as 
a direct result from the BKP procedure.
Discussion
In this case series study, we measured the pre- and postoperative (until at 
least one year after operation) pain levels in 60 patients with painful vertebral 
compression fractures on lumbar and/or thoracic level due to osteoporosis, 
trauma or cancer, who were treated with BKP. The pain intensity levels 
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appeared to be statistically significant different between the pain level at 
baseline and the three moments of measurement after the procedure. No 
statistically significant difference was found between the three moments of 
measurement after the procedure. No statistically significant difference in pain 
intensity was found between the patients with osteoporosis and those with 
cancer between baseline and the first postoperative day.
One patient with cancer died within 1 day after the BKP procedure; the exact 
cause of death is unknown, more specifically a possible contribution to this 
death from the BKP procedure and/or the IV sedation.
 
In support of the recently published papers advocating the use of BKP 
for painful vertebral compression fractures in recent years, and contrary to 
two papers reporting no statistically significant difference of vertebroplasty 
compared to a sham control group, our case series study indicates that BKP 
can result in a statistically significant and sustained pain reduction during 1 
year follow-up. 
This case series study has several limitations: 1) we didn’t include experimental 
control, and therefore cannot compare the treatment results with a control 
group, e.g. a placebo procedure; 2) pain scores were measured during specific 
moments in time; we don’t know if using pain scores reflecting certain periods 
of time might lead to a different result; 3) due to morbidity and mortality 
predominantly occurring in the group of patients with cancer, the number of 
missing data increased as time progressed.
In conclusion, in patients with painful (non)malignant vertebral compression 
fractures, BKP can result in a statistically – and clinically significant pain 
reduction lasting at least one year. Being a spine related pain disorder, patients 
with painful vertebral compression fractures can be referred to pain centers 
having interventional pain physicians performing BKP.
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135GENERAL DISCUSSION
The aim of the work presented in this thesis was to study the effectiveness of 
radiofrequency (RF) treatments for mechanical low back pain. 
Several techniques can be used. We have chosen treatments that resemble the 
common practice in The Netherlands on the moment that we designed the 
studies, namely: RF lesioning with the Simplicity© III tool for SI joint pain 
(Chapter 2), RF lesioning of the ramus dorsalis of the segmental nerve root for 
facet joint pain (Chapter 3) and RF lesioning of the ramus communicans for 
discogenic pain (Chapter 4). Patient selection could be an important prognostic 
factor in treatment success. That is why we studied the inter-rater reliability 
on the diagnostic parameters of the physical examination (Chapter 5) and the 
predictive validity of lumbar X-ray images and MRIs (Chapter 6). Finally, we 
studied the effectiveness of balloon kyphoplasty (BKP) in patients with painful 
vertebral compression fractures due to cancer – and non-cancer etiology 
(Chapter 7).
In this chapter we will present the main findings from our studies in relation 
to existing evidence and we will address some methodological challenges. The 
chapter closes by presenting implications for daily practice and implications for 
further research.
Main findings
Question 1: What is the effectiveness of the RF heat lesion employed for treatment 
of chronic low back pain originating from the SI joint, the facet joint or the 
intervertebral disc?
In Chapter 2, the effect on pain reduction and the global perceived effect (GPE, 
a 7 point Likert scale) were investigated of a percutaneous RF heat lesion 
compared to a sham procedure, applied to the dorsal ramus of L5 and the 
lateral branches of the S1, S2, S3 and S4 nerve roots. There was no statistically 
significant difference in pain level (measured by means of a Numerical Rating 
Scale (NRS) for pain) over time (measurements at baseline, one month 
and three months after the procedure). The same applies to satisfaction and 
recovery, no statistically significant effect was found. 
In Chapter 3, the effect on pain reduction and the GPE were investigated of 
a percutaneous RF heat lesion compared to a sham procedure, applied to the 
medial branch of the primary dorsal ramus of the lumbar facet joints. There 
was a statistically significant effect on the level of pain in the factor period 
(baseline pain level versus the pain level one month after the procedure). 
However, there was no statistically significant difference with the passage of 
time between the treatment and sham groups. Also, there was no statistically 
significant difference in satisfaction or recovery. 
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In Chapter 4, the effect on pain reduction and GPE were investigated of a 
percutaneous RF heat lesion compared to a sham procedure, applied to the 
ramus communicans of the lumbar discs. No statistically significant difference 
in pain level over time (measurements at baseline, one month and three 
months after the procedure) between the treatment and sham groups were 
found. Also, no statistically significant difference in satisfaction or recovery was 
found between the treatment and sham groups.
Based on the results of the sham-controlled trials the H0 hypothesis of no 
difference in pain reduction (NRS) or in GPE between the treatment and the 
sham groups could not be rejected in these three RCTs.
Question 2: What is known about the diagnostic accuracy of the physical 
examination, X-ray imaging and MRIs in diagnosing chronic low back pain 
subtypes?
In Chapter 5, the reliability of diagnostic tests that point towards SI joint –, 
disc – or facet joint pain was investigated. None of the parameters from the 
physical investigation had Kappa (k) values of more than .21 (fair) in all pairs 
of raters. Also, k values for the pooled parameters of the physical examination 
suggestive of SI joint pain stayed below .20 between all raters. The same applies 
for the pooled parameters of the physical examination suggestive of facet joint 
– or disc pain.
In Chapter 6, the diagnostic accuracy of lumbar X-ray imaging and MRIs 
as diagnostic tools of low back pain subtypes was investigated. The positive 
predictive value of X-ray was 82.6% for facet joint pain, 66.7% for disc pain 
and 60% for SI joint pain; the negative predictive value of X-ray was 50% for 
facet joint pain, 66.7% for disc pain and 7.7% for SI joint pain. The positive 
predictive value of MRI was 81.8% for facet joint pain, 50% for disc pain and 
0% for SI joint pain; the negative predictive value of MRI was 55.6% for facet 
joint pain, 0% for disc pain and 13% for SI joint pain. The predictive validity 
of imaging tools investigated to distinguish between low back pain subtypes in 
patients with chronic low back pain is questionable.
Based on the results of the inter-rater reliability study on the diagnostic 
parameters of the physicial examination, as well as of the predictive validity of 
lumbar X-ray images and MRIs, patient selection remains a challenge in the 
treatment of chronic low back pain.
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Question 3: What is the effectiveness of balloon kyphoplasty employed for the 
treatment of patients with painful vertebral compression fractures?
Sixty patients were treated with balloon kyphoplasty (BKP) for painful 
vertebral compression fractures and had follow-up for 1 year. The pain intensity 
levels appeared to be statistically significant different between the pain level 
at baseline (T0) and the three moments of measurement after the procedure, 
p<.001. No statistically significant difference was found between the three 
moments of measurement after the procedure. No statistically significant 
difference in NRS for pain was found between the patients with osteoporosis 
and those with cancer between T0 and T1 (p=.48).
In support of the recently published papers advocating the use of BKP 
for painful vertebral compression fractures in recent years, and contrary to 
two papers reporting no statistically significant difference of vertebroplasty 
compared to a sham control group, our case series study indicates that BKP 
can result in a statistically significant and sustained pain reduction during 1 
year follow-up.
Considerations
Could the results from our studies be explained by 1) patient selection, i.e. the 
results from the diagnostic test block, or 2) by the way how the RF treatments 
were performed and 3) by the choice of the outcome parameters, i.e. the results 
from the diagnostic test block and the RF treatments themselves?
1) On patient selection
Question 4: What is the diagnostic value of the test block?
The percentage of positive diagnostic test blocks was 86.1 in SI joint trial, 77.8 
in the facet joint trial and 64.5 in the ramus communicans trial. Compared 
to earlier studies this is high. The question raises whether a relatively high 
percentage of false positive patients entered the study. Possible explanations for 
these high proportions may be the use of local anaesthetics only, the possible 
spread of the local anaesthetics to pain generating structures other than those 
targeted, the use of only one diagnostic test block instead of two, the use of 
sedation, the combination of multidisciplinary treatment and the criteria 
chosen for the diagnostic test to be called positive1-5. The use of one instead 
of two diagnostic test blocks was chosen because it reflects the Dutch pain 
management practice6-8. 
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When used as prognostic tools before lumbar facet RF lesioning, medial 
branch blocks may be associated with a higher success rate than intra-articular 
injections9. No significant differences were noted between single versus 
multiple blocks. Reducing the volume during cervical medial branch blocks 
may improve precision and accuracy10. The use of intraarticular diagnostic 
facet joint blocks cannot be recommended anymore11. But what is the value of 
diagnostic medial branch blocks in clinical practice?
Most RCTs evaluating lumbar facet RF lesioning used single diagnostic test 
blocks as prognostic tools. Cohen et al. studied the chance on a successful 
outcome of no, one or two diagnostic medial branch blocks in patients 
having lumbar RF facet joint lesioning12. In the group of patients without a 
diagnostic medial branch block performed 33% obtained a successful outcome 
at 3 months versus 16% in the group of patients having had one diagnostic 
medial branch block and 22% in the group having had two diagnostic medial 
branch blocks. Based on these results as well as taking into account its cost-
effectiveness, the question may be whether any blocks should be done before 
lumbar facet joint denervation. However, until now diagnostic blocks are 
the only reliable approach to identify the facet joints as the source of pain13. 
In the absence of a reference standard, medial branch blocks serve more of 
a prognostic than a diagnostic role, enabling the selection of patients who 
might respond to RF denervation treatment. Using double blocks reduces 
the false positive rate of medial branch blocks, but will invariably reduce the 
overall treatment success rate. By increasing the number of diagnostic blocks, 
the false positive rate will be reduced but the false negative rate will increase, 
thus increasing the risk of withholding an active treatment from patients11. 
And what about the balance of the burden of multiple interventions versus the 
potential benefit?
There were no statistically significant differences in RF outcomes based on any 
medial branch block with a pain relief cutoff over 50%14. No optimal threshold 
for designating a diagnostic block as positive, above 50% pain relief, could 
be calculated. Employing more stringent selection criteria is likely to result 
in withholding a beneficial procedure from a substantial number of patients, 
without improving success rates. 
When the RF treatment after a positive diagnostic test block does not lead to a 
statistically (and clinically) significant pain reduction, does that mean that the 
diagnostic test block was an invalid predictor of the effect of a RF treatment 
(i.e. led to false positives)? Does this mean that the diagnostic test block is 
a different treatment as compared to the RF treatment and, therefore, is it a 
poor predictor of the treatment outcome? As suggested by Maas et al., the 
diagnostic accuracy of the test block should be studied15.
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Question 5: What is the contribution of other parameters than RF treatment to the 
prediction of pain relief ?
In order to evaluate the possible contribution of other parameters than the 
RF treatment to the prediction of pain relief, we analysed multiple parameters 
(gender, body mass index, duration of symptoms, the level of pain at baseline, 
age and the interaction between group and age) and found that – in the facet 
joint RCT – age and the level of pain at baseline contributed to the prediction 
of a statistically significant decrease in lumbar facet joint pain; i.e. the younger 
the patient and the higher the pain at baseline, the higher the contribution to 
the prediction of this decrease in pain. However, in the disc RCT we found 
that none of the parameters investigated contributed to the prediction of a 
statistically significant decrease in disc pain.
2) On the way studies were performed
Several studies that have investigated the use of percutaneous RF current 
to diminish SI joint pain describe a success ratio between 64% and 80%16-
18. The application of RF current can be provided in several ways (pulsed or 
continuous, side of the lesion, number of lesions, cooled versus non-cooled)19-24. 
Several devices are commercially available, e.g. (P)RF single needles, cooled 
RF single needles, and multi-electrode RF probes. We have used a multi-
electrode RF probe that has a unique design that allows for positioning using 
a single percutaneous entry point. With this procedure the lateral branches 
of S1, S2, S3 and S4 are targeted at the same time (a L5 dorsal root ramus 
radiofrequency lesioning is performed separately with a single RF needle). 
There were no RCTs available on the efficacy of a multi-electrode RF probe in 
the treatment of SI joint pain. We performed a RCT with the aim to study the 
efficacy of this device. More recently evidence emerged about the use of cooled 
RF current in providing a significant and long lasting pain relief25-30.
We observed several limitations. First, due to the construction of the RF probe 
and the anatomy of the sacrum, we sometimes couldn’t reach the S4 branch. 
However, we don’t know what the exact contribution of the S4 branch holds 
towards SI joint pain. Second, the size of the heat lesion by the RF probe with 
three independent active electrodes might be smaller than the one from the 
cooled RF treatment variant30. Third, the presence of pain distal to the knee in 
patients with SI joint pain is described but not often found.
Age was not normally (bimodally) distributed. This might reflect differences 
in disease type in younger and older people, encompassing different structures 
(diastasis from pregnancy and childbirth, anatomical changes and disorders of 
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the capsuloligamentous structures, and disorders from the vascular plexus or 
complex neural network) and operative procedures31,33. These differences should 
be investigated further in studies on the treatment of SI joint pain.
Recent systematic reviews13,33,34 regarding RF treatment for facet joint pain 
have identified six RCTs investigating the efficacy of the radiofrequency lesion 
on the medial branch of the primary dorsal ramus. Three small studies35-37 
were positive, two were equivocally positive13,34, and one was negative38. The 
overall quality of the evidence of the studies was low to moderate. Lack 
of concealment of allocation and failure to blind patients was reported in 
several trials, and the risk of selective reporting in all trials. For this reason, we 
developed a new RCT.
Depending on the median duration of the symptoms, decrease in pain is 
unlikely to be due to spontaneous recovery in our RCT. In addition, the 
regression analysis revealed no statistically significant effect of the interaction 
of group and age. Therefore, a possible overall effect of treatment due to the 
imbalance in age between the two groups is unlikely. 
We did not test the patients for the success of blinding. However, since the 
results of the crossover, when the patients knew that they would receive 
the real radiofrequency heat lesion, were comparable, we do not think this 
compromised the results.
Age distribution was skewed but other parameters were normally distributed. 
Regression analysis revealed no statistically significant effect of the interaction 
of group and age. Therefore, a possible overall effect of treatment due to the 
imbalance in age between the two groups is unlikely.
To evaluate the efficacy of a percutaneous RF treatment at the ramus 
communicans, two studies36,37 were performed. Methodological differences 
exist in these studies concerning the inclusion criteria, outcome parameters 
and follow-up. In a systematic review33 addressing RF treatment for low back 
pain subtypes, differences between the studies were observed regarding RF 
technique, duration of low back pain before entering the study, the exclusion 
criteria and the number of participants. In the study from Kapural et al.38, the 
sham procedure was not the same as the actual RF treatment. Kapural et al. 
made use of a positive response to diagnostic discography instead of a decrease 
in NRS of 2 or more from a diagnostic test block at the ramus communicans as 
an inclusion parameter, like we did in our study.
A comprehensive understanding of spinal innervation is needed to increase 
to effectiveness of pain treatment39,40. The sinuvertebral nerves that innervate 
the lumbar discs are formed by a somatic root from a ventral ramus and 
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an autonomic root from a grey ramus communicans; an ascending branch 
passes as far as the next higher intervertebral disc, while a descending branch 
supplies the disc at the level of entry41. Two types of rami communicantes are 
observed, a superior oblique ramus and a deep transverse ramus; sinuvertebral 
nerves originate from the deep transverse rami42. These deep transverse rami 
run close to the vertebral bodies and along the lumbar arteries and veins; 
they run along the lateral side of each lumbar vertebral body and connect to 
the corresponding lumbar spinal nerve and sympathetic trunk in a segmental 
manner. All superficial oblique rami run upon the surface of the aponeurosis, 
while the deep transverse rami run beneath the aponeurosis. In this way, using 
fluoroscopic guidance, together with sensory – and motor stimulation, we have 
tried to interrupt the pain impulses with high frequency energy at the site 
of origin. We have targeted the deep transverse ramus (and a root from the 
ventral ramus), while the superior oblique ramus (running upon the surface 
of the aponeurosis) ascends to the next higher intervertebral disc. Due to the 
complexity (and convergence) of lumbar spinal innervation, perhaps treatment 
should be aimed at different structures than we nowadays routinely use?
In support of the recently published papers advocating the use of BKP 
for painful vertebral compression fractures in recent years, and contrary to 
two papers reporting no statistically significant difference of vertebroplasty 
compared to a sham control group, our case series study indicates that BKP 
can result in a statistically significant and sustained pain reduction during 1 
year follow-up.
This case series study has several limitations: 1) we didn’t include experimental 
control, and therefore cannot compare the treatment results with a control 
group, e.g. a placebo procedure; 2) pain scores were measured during specific 
moments in time; we don’t know if using pain scores reflecting certain periods 
of time might lead to a different result; 3) due to morbidity and mortality 
predominantly occurring in the group of patients with cancer, the number of 
missing data increased as time progressed.
Randomisation was performed using sealed envelopes, which the patients 
chose randomly. In this way, patients as well as their pain physicians were 
completely unaware of the content of the envelope during any stage of the 
investigation. The pain research nurse was the only one aware of the contents 
and performed the treatment accordingly. 
Regarding the radiofrequency generator, all sound indicators were turned off 
and the generator itself was visually hidden from the patient by means of a 
linen cloth, hung between two metal infusion poles. The pain physician left the 
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operating theatre when the actual treatment (RF current or sham) took place. 
The same time period was taken for an actual – or a sham treatment. 
A limitation is that we did not test the patients for the success of blinding. 
However, since the results of the crossover studies performed - when 
the patients knew that they would receive the real RF heat lesion - were 
comparable, we do not think this compromised the results.
All patients received graded activity physiotherapy, but not at one single center. 
Perhaps there were differences in the frequency and way patients were treated 
at the different centers. It was difficult for us to gain evidence on equal quality 
of physiotherapy accompaniment. However, there were no differences in the 
way patients from the actual treatment and sham groups were referred. Hence, 
we cannot assume a systematically different treatment between the groups.
3) On the choice of the outcome parameters
In the RCT on the efficacy of percutaneous RF current to diminish facet 
joint pain we analysed a possible association between the amount of pain 
reduction after the diagnostic test block and after the intervention and found 
no statistically significant correlation between these parameters. Could the 
amount of pain reduction after the diagnostic test block possibly not to be 
related to the amount of the pain reduction after the intervention? Further 
studies should confirm this observation.
A patient was considered to have a successful outcome in case of a reduction 
equal to or greater than the minimal clinically important change for pain. The 
minimal clinically important change is the least improvement that patients rate 
as rendering them better than they were. For back pain, it is an NRS of 2 out 
of 10 points43. These patients nevertheless continue to have pain. What patients 
consider as an improvement might be different from this minimal important 
change in pain, e.g. 50% or 80%44. Inquiring about patients’ expectations 
of reduction in pain is important in establishing realistic treatment goals. 
Minimal clinically important changes might fall short.
Recommendations on outcome measures for chronic pain trials were 
described in 200545. Besides outcome measures on pain, global improvement 
and satisfaction, other outcome measures include physical and emotional 
functioning, symptoms and adverse events, and participant disposition. Core 
outcome sets for research and clinical practice in various domains have been 
introduced46. 
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Implications for clinical practice and future research
This thesis shows that although percutaneous RF treatment for chronic 
mechanical low back pain is frequently used, evidence for the effect of this 
treatment in the way we performed the RF procedures is not supported. The 
results of the inter-rater reliability study on the parameters of the physical 
examination and the diagnostic accuracy study of lumbar X-ray imaging and 
MRIs leaves us faced with the challenges that come with patient selection in 
the case of chronic low back pain trials.
Future studies should establish: i) the diagnostic accuracy of the test block; 
ii) the identification of subgroups of patients with low back pain that may 
benefit from RF treatment; iii) unification of anatomical sites targeted for 
RF treatment; iv) targeting new anatomical sites based on a comprehensive 
understanding of anatomy; v) and unification of outcome parameters in (low 
back) pain trials. 
The aim of all the studies is to further improve the diagnosis and treatment of 
patients with chronic spine related pain disorders.
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This dissertation on the effectiveness of minimally invasive treatment for 
chronic lumbar spine related pain disorders is divided into eight chapters. 
After the introduction on low back pain and its management, followed by 
the outline of the thesis and the problem formulation, chapter two describes 
the randomised sham-controlled double blind multicentre trial to ascertain 
the effect of percutaneous radiofrequency (RF) treatment for SI joint pain. 
Chapter three describes the randomised sham-controlled double blind 
multicentre clinical trial to ascertain the effect of percutaneous RF treatment 
for lumbar facet joint pain. The randomised sham-controlled double blind 
multicentre clinical trial to ascertain the effect of percutaneous RF treatment 
at the ramus communicans for lumbar disc pain is described in chapter four. 
Chapter five describes the inter-rater reliability of the diagnostic criteria for SI 
joint –, disc – and facet joint pain, chapter six the predictive validity of X-ray 
images and MRIs of the lumbar spine. The effectiveness of balloon kyphoplasty 
in patients with painful vertebral compression fractures is described in chapter 
seven. Chapter eight is a general discussion of the main findings, strengths and 
limitations of all studies in this thesis.
The introductory chapter describes (prevalence rates for) chronic low back 
pain and the evaluation of the pain producing structures. I review the available 
evidence on treatment possibilities and specifically address the question of lack 
of sound evidence on the effectiveness of minimally invasive treatment, leading 
to the rationale of this thesis.
The reports on the results of the three sham-controlled RCTs on the 
effectiveness in terms of pain relief of percutaneous RF for chronic low back 
pain are described in chapters two, three and four. Each RCT included 60 
patients who were randomised to receive the actual (RF) or sham treatment. 
The main study parameter was pain reduction (NRS) with the secondary study 
parameter being global perceived effect (GPE). In all RCTs the pooled data 
from both groups showed a statistically significant pain reduction between T0 
(before the treatment) and T1 (1 month after the treatment). However, the 
hypothesis (H0) of no differences in terms of pain relief or in GPE between 
the groups could not be rejected. In other words, percutaneous RF when 
comparing to a sham intervention does not lead to a statistically significant 
more substantial pain reduction, nor to a more substantial GPE.
Very little is known about the inter-rater reliability of the diagnostic criteria 
to identify low back pain subtypes. The study to determine the reliability 
of diagnostic tests that should indicate SI joint –, disc – or facet joint pain 
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represents the contents of chapter five. One hundred patients were included. 
The inter-rater reliability was estimated using Cohen’s Kappa (k) index. The 
null hypothesis was an agreement of not bigger than coincidence (Kappa 
= 0). There was no Kappa value of more than .21 (fair) for each individual 
physical test in all raters together. The Kappa values for the pooled items for 
SI joint –, disc – and facet joint pain were less than .20 in all raters together. 
The inter-rater reliability of the diagnostic tests appeared to be small and this 
fact seriously limits their predictive validity. The practical value of the tests 
investigated in patients with low back pain for more than three months thereby 
seems to be doubtful.
The current evidence regarding the predictive validity of imaging tests of 
the lumbar spine to identify the source of low back pain is inconsistent and 
does not help to determine their role. The predictive validity of X-ray images 
and MRIs of the lumbar spine is written down in chapter six. One hundred 
patients were included. The positive predictive value of X-ray was 82.6% for 
facet joint pain, 66.7% for disc pain and 60% for SI joint pain; the negative 
predictive value of X-ray was 50% for facet joint pain, 66.7% for disc pain 
and 7.7% for SI joint pain. The positive predictive value of MRI was 81.8% 
for facet joint pain, 50% for disc pain and 0% for SI joint pain; the negative 
predictive value of MRI was 55.6% for facet joint pain, 0% for disc pain and 
13% for SI joint pain. The predictive validity (and as such their practical value) 
of X-ray images and MRIs of the lumbar spine to identify the source of low 
back pain appears to be doubtful.
Several studies report that cement augmentation provides better clinical 
outcome compared to non-surgical management in patients with painful 
vertebral compression fractures due to cancer and non-cancer etiology, 
although in two RCTs the treatment and sham groups demonstrated similar 
results. In our case series study of 60 patients treated with BKP a statistically 
significant effect (p<.001) was demonstrated between the pain level at baseline 
and the three moments of measurement after the procedure. No statistically 
significant effect was found (p=.48) in the pain level at baseline and the first 
postoperative day between the patients with vertebral compression fractures 
due to osteoporosis and those with vertebral compression fractures due 
to cancer. In patients with painful (non)malignant vertebral compression 
fractures, BKP can result in a statistically – and clinically significant pain 
reduction lasting at least one year.
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Deze dissertatie over de effectiviteit van minimaal invasieve behandeling 
van chronische wervelkolomgerelateerde pijnklachten van de lage rug is 
onderverdeeld in zeven hoofdstukken. Na de inleiding over de last van 
lage rugklachten en haar behandeling, gevolgd door de uiteenzetting van 
de thesis en formulering van de problematiek beschrijft hoofdstuk twee de 
gerandomiseerde, sham-gecontroleerde, dubbelblinde multicenter studie 
naar het effect van percutane radiofrequente (RF) behandeling voor SI 
gewrichtsklachten. Hoofdstuk drie beschrijft de gerandomiseerde, sham-
gecontroleerde, dubbelblinde multicenter studie naar het effect van percutane 
RF behandeling voor lumbale facetgewricht pijnklachten. De gerandomiseerde, 
sham-gecontroleerde, dubbelblinde multicenter studie naar het effect van 
percutane RF behandeling ter hoogte van de ramus communicans voor 
pijnklachten afkomstig van de lumbale tussenwervelschijf wordt beschreven in 
hoofdstuk vier. Hoofdstuk vijf beschrijft de inter-beoordelaar betrouwbaarheid 
van de diagnostische criteria voor SI gewricht –, tussenwervelschijf – en 
facetgewricht pijnklachten tussen de beoordelaars, hoofdstuk zes predictieve 
validiteit van röntgenfoto’s en MRI’s van de lendenwervels. Hoofdstuk zeven 
is een algemene discussie over de voornaamste bevindingen, sterktes en 
beperkingen van alle studies in deze thesis.
Het inleidende hoofdstuk is beschrijft de (prevalentie cijfers voor) chronische 
lage rugklachten en de evaluatie van weefsels welke pijn genereren. Ik blik 
terug op het beschikbare bewijs omtrent behandelingsmogelijkheden en ga 
specifiek in op het gebrek aan sterke bewijsvoering betreffende de effectiviteit 
van minimaal invasieve behandeling, leidend tot de rationale van deze thesis.
De rapportage over de resultaten van drie sham-gecontroleerde RCT’s 
betreffende de effectiviteit in termen van pijnverlichting van percutane RF 
voor chronische lage rugklachten staan beschreven in de hoofdstukken 
twee, drie en vier. In iedere RCT werden 60 patiënten geïncludeerd welke 
werden gerandomiseerd om ofwel de werkelijke (RF) of sham behandeling te 
ontvangen. De belangrijkste studie parameter was pijnvermindering (NRS) 
en de tweede studie parameter was globaal ervaren effect (Global Perceived 
Effect, GPE). Voor alle RCT’s geldt dat de data van beide groepen gepooled 
een statistisch significante pijnreductie laten zien tussen T0 (voorafgaande aan 
de behandeling) en T1 (één maand na de behandeling). Echter, de hypothese 
(H0) van geen verschil in vermindering van pijnklachten of in GPE tussen de 
groepen kon niet worden verworpen. Met andere woorden, percutane RF in 
vergelijking met de sham interventie leidt niet tot een statistisch significant 
grotere pijnverlichting, evenmin tot een groter globaal ervaren effect.
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Er is weinig bekend over de inter-beoordelaar betrouwbaarheid van de 
diagnostische criteria voor subtypering van chronische lage rugklachten. De 
studie betreffende de inter-beoordelaar betrouwbaarheid van diagnostische 
fysieke tests die zouden indiceren of het SI gewricht –, de tussenwervelschijf 
– of het facetgewricht de pijnklachten geeft wordt beschreven in hoofdstuk 
vijf. Honderd patiënten werden geïncludeerd. De inter-beoordelaar 
betrouwbaarheid werd geschat met behulp van Cohen’s Kappa (k) index. 
De nul hypothese was dat er geen grotere overeenstemming is tussen de 
beoordelaars dan op grond van toeval kan worden verwacht (Kappa = 0). 
Er werd geen Kappa waarde gevonden van meer dan .21 (redelijk) voor de 
individuele fysieke tests tussen alle beoordelaars. De Kappa waarden voor 
de samengevoegde onderdelen voor SI gewricht –, tussenwervelschijf – of 
facetgewricht pijnklachten waren kleiner dan .20 tussen alle beoordelaars. De 
inter-beoordelaar betrouwbaarheid van de diagnostische tests bleek dus gering 
en dit feit beperkt hun predictieve waarde in hoge mate. Daarmee lijkt de 
praktische waarde van de onderzochte tests bij gebruik in patiënten met lage 
rugklachten welke langer dan drie maanden aanwezig zijn twijfelachtig.
De huidige bewijsvoering van de predictieve validiteit van beeldvormend 
onderzoek van de lendenwervels voor het identificeren van de bron van lage 
rugpijn is onsamenhangend, waardoor de rol van dit onderzoek onduidelijk 
was. In hoofdstuk zes wordt het onderzoek naar de predictieve validiteit van 
röntgenfoto’s en MRI’s van de lendenwervels beschreven. Honderd patiënten 
werden geïncludeerd. De positieve predictieve waarde van röntgenfoto’s was 
82.6% voor facetgewricht pijnklachten, 66.7% voor discogene pijnklachten 
en 60% van SI pijnklachten; de negatieve predictieve waarde was 50% voor 
facetgewricht pijnklachten, 66.7% voor discogene pijnklachten en 7.7% voor 
SI pijnklachten. De positieve predictieve waarde van MRI was 81.8% voor 
facetgewricht pijnklachten, 50% voor discogene pijnklachten en 0% voor SI 
pijnklachten; de negatieve predictieve waarde was 55.6% voor facetgewricht 
pijnklachten, 0% voor discogene pijnklachten en 13% voor SI pijnklachten. De 
predicitieve validiteit (en daarmee de praktische waarde) van röntgenfoto’s en 
MRI’s van de lendenwervels voor het identificeren van de bron van lage rugpijn 
bleek dus twijfelachtig te zijn.
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Diverse onderzoeken beschrijven dat wervelcementering betere klinische 
resultaten oplevert in vergelijking met niet-chirurgische behandeling bij 
patiënten met pijnlijke wervelinzakkingen door oncologische – en niet-
oncologische oorzaken, hoewel in twee RCT’s resultaten gelijkaardig waren in 
de behandel– en placebo groep. In onze case series studie werden 60 patiënten 
behandeld met BKP en werd een statistisch significant effect (p<.001) 
aangetoond tussen het pijn niveau voorafgaande aan de behandeling en deze op 
de drie meetmomenten na de behandeling. Er kon geen statistisch significant 
effect (p=.48) worden aangetoond tussen het pijn niveau voorafgaande aan 
de behandeling en deze op de eerste postoperatieve dag bij patiënten met 
wervelinzakkingen door osteoporose en bij hen met met wervelinzakkingen 
door kanker. Bij patiënten met pijnlijke (niet-)oncologische wervelinzakkingen 
kan BKP een statistisch – en klinisch significante pijnvermindering opleveren 
welke gedurende tenminste één jaar aanhoudt.
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"There are three kinds of Budoka: one that tries to look strong, one that 
tries to perfect the technique and one that tries to gain a good heart."
Masaaki Hatsumi (1931-)
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